Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References FTP Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer ACP Haplotyper Genome Scanner
Aging & Age-Related Disease Cancer Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:homopolysaccharide
go back to main search page
Accession:CHEBI:37164 term browser browse the term
Definition:Glycans composed of a single type of monosaccharide residue. They are named by replacing the ending '-ose' of the sugar by '-an'.
Synonyms:related_synonym: homoglycan;   homopolysaccharides

show annotations for term's descendants           Sort by:
 
(1->3)-beta-D-glucan term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G S100b S100 calcium binding protein B increases expression ISO beta-1,3-D-glucan results in increased expression of S100B protein CTD PMID:28117141 NCBI chr20:13,130,633...13,142,856
Ensembl chr20:13,130,636...13,142,856 		JBrowse link
G Tslp thymic stromal lymphopoietin increases expression ISO (1->3)-beta-D-glucan increases expression of TSLP mRNA and protein in corneal epithelial cells RGD PMID:26874828 RGD:38549373 NCBI chr18:25,613,601...25,618,066
Ensembl chr18:25,613,831...25,617,361 		JBrowse link
G Uchl1 ubiquitin C-terminal hydrolase L1 increases expression ISO beta-1,3-D-glucan results in increased expression of UCHL1 protein CTD PMID:28117141 NCBI chr14:43,133,224...43,143,942
Ensembl chr14:43,133,218...43,143,973 		JBrowse link
(1->4)-beta-D-glucan term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Nos2 nitric oxide synthase 2 increases expression EXP Cellulose analog results in increased expression of NOS2 protein CTD PMID:29458016 NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 increases expression EXP Cellulose analog results in increased expression of PTGS2 protein CTD PMID:29458016 NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO Cellulose analog inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF mRNA] CTD PMID:21354485 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000 		JBrowse link
arabinoxylan term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Fgf7 fibroblast growth factor 7 increases expression ISO arabinoxylan results in increased expression of FGF7 mRNA CTD PMID:15678371 NCBI chr 3:118,315,859...118,368,464
Ensembl chr 3:118,317,761...118,366,872 		JBrowse link
beta-cyclodextrin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akt1 AKT serine/threonine kinase 1 multiple interactions ISO betadex inhibits the reaction [sodium arsenite results in increased phosphorylation of AKT1 protein] CTD PMID:12614848 NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258 		JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO betadex inhibits the reaction [sodium arsenite results in increased phosphorylation of JUN protein] CTD PMID:11035063 NCBI chr 5:114,011,184...114,014,277
Ensembl chr 5:114,011,189...114,014,277 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 multiple interactions ISO betadex inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein] CTD PMID:11035063 NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions ISO betadex inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK3 protein] CTD PMID:11035063 NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase 1 multiple interactions ISO betadex inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein] CTD PMID:11035063 NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716 		JBrowse link
G Tfeb transcription factor EB affects localization ISO betadex affects the localization of TFEB protein CTD PMID:28366621 NCBI chr 9:15,208,141...15,264,101
Ensembl chr 9:15,207,822...15,214,596 		JBrowse link
G Thy1 Thy-1 cell surface antigen multiple interactions ISO betadex inhibits the reaction [sodium arsenite promotes the reaction [THY1 protein binds to THY1 protein]] CTD PMID:11035063 NCBI chr 8:48,382,121...48,387,271
Ensembl chr 8:48,382,121...48,386,935 		JBrowse link
beta-D-glucan term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Ccl2 C-C motif chemokine ligand 2 increases expression ISO beta-Glucans results in increased expression of CCL2 protein CTD PMID:17572156 NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870 		JBrowse link
G Cd40 CD40 molecule increases expression ISO beta-Glucans results in increased expression of CD40 protein CTD PMID:17572156 NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704 		JBrowse link
G Cd69 Cd69 molecule increases expression ISO beta-Glucans results in increased expression of CD69 protein CTD PMID:17572156 NCBI chr 4:163,041,147...163,049,065
Ensembl chr 4:163,041,141...163,049,084 		JBrowse link
G Cd80 Cd80 molecule increases expression ISO beta-Glucans results in increased expression of CD80 protein CTD PMID:17572156 NCBI chr11:64,815,201...64,855,293
Ensembl chr11:64,827,635...64,855,353 		JBrowse link
G Cd86 CD86 molecule increases expression ISO beta-Glucans results in increased expression of CD86 protein CTD PMID:17572156 NCBI chr11:67,060,305...67,117,990
Ensembl chr11:67,082,193...67,118,795 		JBrowse link
G Fmo2 flavin containing dimethylaniline monoxygenase 2 increases expression ISO beta-Glucans results in increased expression of FMO2 mRNA CTD PMID:27910771 NCBI chr13:80,752,526...80,775,264
Ensembl chr13:80,755,058...80,775,264 		JBrowse link
G Fmo3 flavin containing dimethylaniline monoxygenase 3 increases expression ISO beta-Glucans results in increased expression of FMO3 mRNA CTD PMID:27910771 NCBI chr13:80,837,418...80,856,214
Ensembl chr13:80,837,420...80,862,963 		JBrowse link
G Fmo4 flavin containing dimethylaniline monoxygenase 4 increases expression ISO beta-Glucans results in increased expression of FMO4 mRNA CTD PMID:27910771 NCBI chr13:80,685,385...80,703,575
Ensembl chr13:80,685,325...80,703,615 		JBrowse link
G Ifng interferon gamma multiple interactions ISO [beta-Glucans co-treated with resiquimod co-treated with IFNG protein] results in increased expression of IL12A mRNA; IFNG protein inhibits the reaction [beta-Glucans results in increased expression of [IL12B protein binds to IL23A protein]]; IFNG protein inhibits the reaction [beta-Glucans results in increased expression of IL10 mRNA]; IFNG protein inhibits the reaction [beta-Glucans results in increased expression of IL10 protein]; IFNG protein inhibits the reaction [beta-Glucans results in increased expression of IL23A mRNA]; IFNG protein promotes the reaction [beta-Glucans results in increased expression of [IL12A protein binds to IL12B protein]] CTD PMID:18490488 NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419 		JBrowse link
G Il10 interleukin 10 increases expression
multiple interactions		 ISO beta-Glucans results in increased expression of IL10 mRNA; beta-Glucans results in increased expression of IL10 protein
IFNG protein inhibits the reaction [beta-Glucans results in increased expression of IL10 mRNA]; IFNG protein inhibits the reaction [beta-Glucans results in increased expression of IL10 protein]; resiquimod promotes the reaction [beta-Glucans results in increased expression of IL10 mRNA]; resiquimod promotes the reaction [beta-Glucans results in increased expression of IL10 protein]		 CTD PMID:18490488 NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392 		JBrowse link
G Il12a interleukin 12A multiple interactions ISO [beta-Glucans co-treated with resiquimod co-treated with IFNG protein] results in increased expression of IL12A mRNA; [beta-Glucans co-treated with resiquimod] results in increased expression of [IL12A protein binds to IL12B protein]; IFNG protein promotes the reaction [beta-Glucans results in increased expression of [IL12A protein binds to IL12B protein]] CTD PMID:18490488 NCBI chr 2:165,076,945...165,083,996
Ensembl chr 2:165,076,607...165,084,318 		JBrowse link
G Il12b interleukin 12B multiple interactions
increases expression		 ISO [beta-Glucans co-treated with resiquimod] results in increased expression of [IL12A protein binds to IL12B protein]; beta-Glucans results in increased expression of [IL12B protein binds to IL23A protein]; IFNG protein inhibits the reaction [beta-Glucans results in increased expression of [IL12B protein binds to IL23A protein]]; IFNG protein promotes the reaction [beta-Glucans results in increased expression of [IL12A protein binds to IL12B protein]]; resiquimod promotes the reaction [beta-Glucans results in increased expression of [IL12B protein binds to IL23A protein]]; resiquimod promotes the reaction [beta-Glucans results in increased expression of IL12B protein] CTD PMID:18490488 NCBI chr10:30,034,447...30,048,774
Ensembl chr10:30,038,709...30,048,085 		JBrowse link
G Il23a interleukin 23 subunit alpha multiple interactions
increases expression		 ISO beta-Glucans results in increased expression of [IL12B protein binds to IL23A protein]; IFNG protein inhibits the reaction [beta-Glucans results in increased expression of [IL12B protein binds to IL23A protein]]; IFNG protein inhibits the reaction [beta-Glucans results in increased expression of IL23A mRNA]; resiquimod promotes the reaction [beta-Glucans results in increased expression of [IL12B protein binds to IL23A protein]]; resiquimod promotes the reaction [beta-Glucans results in increased expression of IL23A mRNA] CTD PMID:18490488 NCBI chr 7:2,710,609...2,712,723
Ensembl chr 7:2,710,609...2,712,723 		JBrowse link
G Il6 interleukin 6 multiple interactions
increases expression		 ISO 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [beta-Glucans results in increased expression of IL6 protein]; MYD88 gene mutant form inhibits the reaction [beta-Glucans results in increased secretion of IL6 protein] CTD PMID:17572156 NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807 		JBrowse link
G Myd88 MYD88, innate immune signal transduction adaptor multiple interactions ISO MYD88 gene mutant form inhibits the reaction [beta-Glucans results in increased secretion of IL6 protein]; MYD88 gene mutant form inhibits the reaction [beta-Glucans results in increased secretion of TNF protein] CTD PMID:17572156 NCBI chr 8:128,022,512...128,027,462
Ensembl chr 8:128,022,473...128,026,841 		JBrowse link
G Syk spleen associated tyrosine kinase increases phosphorylation ISO beta-Glucans results in increased phosphorylation of SYK protein CTD PMID:17572156 NCBI chr17:12,614,311...12,669,568
Ensembl chr17:12,614,311...12,669,573 		JBrowse link
G Tnf tumor necrosis factor multiple interactions
increases expression		 ISO 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [beta-Glucans results in increased expression of TNF protein]; MYD88 gene mutant form inhibits the reaction [beta-Glucans results in increased secretion of TNF protein] CTD PMID:17572156 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000 		JBrowse link
carrageenan term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akt1 AKT serine/threonine kinase 1 increases phosphorylation
multiple interactions		 ISO Carrageenan results in increased phosphorylation of AKT1 protein
fucoxanthin inhibits the reaction [Carrageenan results in increased phosphorylation of AKT1 protein]		 CTD PMID:26418808 NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258 		JBrowse link
G Anxa1 annexin A1 affects response to substance
multiple interactions		 ISO ANXA1 protein affects the susceptibility to Carrageenan
ANXA1 protein affects the susceptibility to [Dexamethasone co-treated with Carrageenan]		 CTD PMID:12475898 NCBI chr 1:237,893,983...237,910,002
Ensembl chr 1:237,893,966...237,910,012 		JBrowse link
G Apcs amyloid P component, serum increases expression EXP Carrageenan results in increased expression of APCS protein CTD PMID:22330755 NCBI chr13:91,426,621...91,427,417
Ensembl chr13:91,426,479...91,427,575 		JBrowse link
G Cat catalase multiple interactions
decreases activity		 ISO
EXP		 fucoxanthin inhibits the reaction [Carrageenan results in decreased activity of CAT protein]
procyanidin B2 inhibits the reaction [Carrageenan results in decreased activity of CAT protein]		 CTD PMID:26418808 PMID:28844677 NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions
increases expression		 ISO 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid inhibits the reaction [Carrageenan results in increased expression of CCL2 protein] CTD PMID:12444156 PMID:20383154 NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 multiple interactions
increases expression		 ISO 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid inhibits the reaction [Carrageenan results in increased expression of CCL3 protein] CTD PMID:12444156 PMID:20383154 NCBI chr10:70,869,516...70,871,066
Ensembl chr10:70,869,513...70,871,066 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 increases expression
multiple interactions		 ISO
EXP		 Carrageenan results in increased expression of CCL5 protein
isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein]; Quercetin inhibits the reaction [Carrageenan results in increased expression of CCL5 protein]		 CTD PMID:12444156 PMID:14654164 NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315 		JBrowse link
G Cma1 chymase 1 multiple interactions
increases expression		 EXP adelmidrol inhibits the reaction [Carrageenan results in increased expression of CMA1 protein] CTD PMID:18429935 NCBI chr15:34,601,037...34,603,819
Ensembl chr15:34,601,037...34,603,819 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 multiple interactions
increases secretion
increases expression		 EXP
ISO		 IMMLG5521 inhibits the reaction [Carrageenan results in increased secretion of CXCL2 protein]; isoquercitrin inhibits the reaction [Carrageenan results in increased expression of CXCL2 protein] CTD PMID:12444156 PMID:14654164 PMID:21549112 NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 increases expression ISO Carrageenan results in increased expression of CXCL1 protein CTD PMID:12444156 NCBI chr14:18,820,168...18,839,659
Ensembl chr14:18,820,168...18,839,595 		JBrowse link
G Egr1 early growth response 1 increases expression
multiple interactions		 ISO Carrageenan results in increased expression of EGR1 protein
3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Carrageenan results in increased expression of EGR1 protein]; EGR1 protein inhibits the reaction [Carrageenan results in decreased expression of and affects the localization of TJP1 protein]; NFKBIA protein inhibits the reaction [Carrageenan results in increased expression of EGR1 protein]		 CTD PMID:22561171 NCBI chr18:27,657,903...27,660,101
Ensembl chr18:27,657,628...27,661,429 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions
increases expression		 EXP 3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one inhibits the reaction [Carrageenan results in increased expression of FOS protein]; Flurbiprofen inhibits the reaction [Carrageenan results in increased expression of FOS protein]; Flurbiprofen promotes the reaction [Urethane inhibits the reaction [Carrageenan results in increased expression of FOS protein]]; Urethane inhibits the reaction [Carrageenan results in increased expression of FOS protein]; Urethane inhibits the reaction [Flurbiprofen inhibits the reaction [Carrageenan results in increased expression of FOS protein]] CTD PMID:1327382 PMID:11164833 NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299 		JBrowse link
G Gal galanin and GMAP prepropeptide decreases response to substance ISO GAL protein results in decreased susceptibility to Carrageenan CTD PMID:17999197 NCBI chr 1:218,653,059...218,657,922
Ensembl chr 1:218,652,917...218,657,925 		JBrowse link
G Gpr132 G protein-coupled receptor 132 increases expression ISO Carrageenan results in increased expression of GPR132 mRNA CTD PMID:19602228 NCBI chr 6:137,652,213...137,671,658
Ensembl chr 6:137,652,213...137,664,133 		JBrowse link
G Gpr4 G protein-coupled receptor 4 increases expression ISO Carrageenan results in increased expression of GPR4 mRNA CTD PMID:19602228 NCBI chr 1:80,125,639...80,136,786
Ensembl chr 1:80,135,391...80,136,880 		JBrowse link
G Gpr65 G-protein coupled receptor 65 increases expression ISO Carrageenan results in increased expression of GPR65 mRNA CTD PMID:19602228 NCBI chr 6:122,248,528...122,256,115
Ensembl chr 6:122,254,841...122,256,251 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
decreases expression		 EXP procyanidin B2 inhibits the reaction [Carrageenan results in decreased expression of HMOX1 protein] CTD PMID:28844677 NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456 		JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A increases expression EXP Carrageenan results in increased expression of HSPA1A protein CTD PMID:15860553 NCBI chr20:4,875,834...4,881,751
Ensembl chr20:4,877,324...4,879,779 		JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions
increases expression		 EXP
ISO		 2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone inhibits the reaction [Carrageenan results in increased expression of ICAM1 protein]]; Carrageenan promotes the reaction [Lipopolysaccharides results in increased expression of ICAM1 mRNA]; Dexamethasone inhibits the reaction [Carrageenan results in increased expression of ICAM1 mRNA]; Fluvoxamine inhibits the reaction [Carrageenan results in increased expression of ICAM1 mRNA]; imisopasem manganese inhibits the reaction [Carrageenan results in increased expression of ICAM1 protein]; rosiglitazone inhibits the reaction [Carrageenan results in increased expression of ICAM1 protein]
IL1R1 protein promotes the reaction [Carrageenan results in increased expression of ICAM1 protein]; PEGylated soluble tumor necrosis factor receptor I inhibits the reaction [Carrageenan results in increased expression of ICAM1 protein]; TNFSF8 protein promotes the reaction [Carrageenan results in increased expression of ICAM1 protein]
Carrageenan results in increased expression of ICAM1 mRNA; Carrageenan results in increased expression of ICAM1 protein		 CTD PMID:11181422 PMID:14709329 PMID:15380531 PMID:22330755 PMID:27803785 NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059 		JBrowse link
G Il10 interleukin 10 increases secretion
multiple interactions
increases expression		 EXP
ISO		 Carrageenan results in increased secretion of IL10 protein
indole-3-guanylhydrazone hydrochloride promotes the reaction [Carrageenan results in increased secretion of IL10 protein]; Indomethacin promotes the reaction [Carrageenan results in increased secretion of IL10 protein]
Indomethacin inhibits the reaction [Carrageenan results in increased expression of IL10 mRNA]; procyanidin B2 inhibits the reaction [Carrageenan results in increased secretion of IL10 protein]; Thioctic Acid promotes the reaction [Carrageenan results in increased expression of IL10 mRNA]		 CTD PMID:11181422 PMID:19735303 PMID:28844677 PMID:29499192 NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392 		JBrowse link
G Il1a interleukin 1 alpha multiple interactions
decreases expression		 ISO Carrageenan inhibits the reaction [Morphine results in decreased expression of IL1A protein]; Dexamethasone inhibits the reaction [Carrageenan inhibits the reaction [Morphine results in decreased expression of IL1A protein]]; Dexamethasone inhibits the reaction [Morphine inhibits the reaction [Carrageenan results in decreased expression of IL1A protein]]; Morphine inhibits the reaction [Carrageenan results in decreased expression of IL1A protein]; Naloxone inhibits the reaction [Carrageenan inhibits the reaction [Morphine results in decreased expression of IL1A protein]]; Naloxone inhibits the reaction [Morphine inhibits the reaction [Carrageenan results in decreased expression of IL1A protein]] CTD PMID:12182845 NCBI chr 3:121,824,712...121,836,122
Ensembl chr 3:121,825,412...121,836,086 		JBrowse link
G Il1b interleukin 1 beta increases secretion
increases expression
multiple interactions		 ISO
EXP		 Carrageenan results in increased secretion of IL1B protein
Carrageenan results in increased expression of IL1B protein
5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid inhibits the reaction [Carrageenan results in increased expression of IL1B protein]; indole-3-guanylhydrazone hydrochloride inhibits the reaction [Carrageenan results in increased secretion of IL1B protein]; Indomethacin inhibits the reaction [Carrageenan results in increased secretion of IL1B protein]
3-methylquercetin inhibits the reaction [Carrageenan results in increased expression of IL1B protein]; budlein A inhibits the reaction [Carrageenan results in increased secretion of IL1B protein]; Carrageenan promotes the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; Dexamethasone inhibits the reaction [Carrageenan results in increased expression of IL1B protein]; imisopasem manganese inhibits the reaction [Carrageenan results in increased expression of IL1B protein]; IMMLG5521 inhibits the reaction [Carrageenan results in increased secretion of IL1B protein]; N-(2-hydroxybenzoyl)tyramine inhibits the reaction [Carrageenan results in increased expression of IL1B protein]		 CTD PMID:11181422 PMID:16368644 PMID:17320857 PMID:20383154 PMID:21549112 PMID:22330755 PMID:23774260 PMID:23872256 PMID:29499192 NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726 		JBrowse link
G Il1r1 interleukin 1 receptor type 1 multiple interactions
increases response to substance		 ISO IL1R1 protein promotes the reaction [Carrageenan results in increased expression of ICAM1 protein]; IL1R1 protein promotes the reaction [Carrageenan results in increased expression of SELP protein]; IL1R1 protein promotes the reaction [Carrageenan results in increased expression of TNF protein]; IL1R1 protein promotes the reaction [Carrageenan results in increased expression of TNFRSF8 protein]; IL1R1 protein promotes the reaction [Carrageenan results in increased expression of TNFSF8 protein]
IL1R1 protein results in increased susceptibility to Carrageenan		 CTD PMID:15380531 NCBI chr 9:46,962,291...47,038,139
Ensembl chr 9:46,962,288...47,036,670 		JBrowse link
G Il6 interleukin 6 multiple interactions
increases expression
increases secretion		 ISO
EXP		 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid inhibits the reaction [Carrageenan results in increased expression of IL6 protein]
3-methylquercetin inhibits the reaction [Carrageenan results in increased expression of IL6 protein]; Carrageenan promotes the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; Diclofenac inhibits the reaction [Carrageenan results in increased expression of IL6 protein]; imisopasem manganese inhibits the reaction [Carrageenan results in increased expression of IL6 protein]; procyanidin B2 inhibits the reaction [Carrageenan results in increased secretion of IL6 protein]; Thiazolidines analog inhibits the reaction [Carrageenan results in increased expression of IL6 protein]		 CTD PMID:11181422 PMID:20383154 PMID:22330755 PMID:23774260 PMID:24412305 PMID:28844677 NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807 		JBrowse link
G Klk7 kallikrein-related peptidase 7 increases expression
multiple interactions		 EXP Carrageenan results in increased expression of KLK3 protein
procyanidin B2 inhibits the reaction [Carrageenan results in increased expression of KLK3 protein]		 CTD PMID:28844677 NCBI chr 1:99,749,991...99,754,723
Ensembl chr 1:99,749,936...99,754,435 		JBrowse link
G Mapk1 mitogen activated protein kinase 1 increases phosphorylation
multiple interactions		 ISO Carrageenan results in increased phosphorylation of MAPK1 protein
fucoxanthin inhibits the reaction [Carrageenan results in increased phosphorylation of MAPK1 protein]; Indomethacin inhibits the reaction [Carrageenan results in increased phosphorylation of MAPK1 protein]		 CTD PMID:26418808 NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254 		JBrowse link
G Mapk3 mitogen activated protein kinase 3 multiple interactions
increases phosphorylation		 ISO fucoxanthin inhibits the reaction [Carrageenan results in increased phosphorylation of MAPK3 protein]; Indomethacin inhibits the reaction [Carrageenan results in increased phosphorylation of MAPK3 protein] CTD PMID:26418808 NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975 		JBrowse link
G Mmp9 matrix metallopeptidase 9 increases expression
multiple interactions		 EXP Carrageenan results in increased expression of MMP9 protein
adelmidrol inhibits the reaction [Carrageenan results in increased expression of MMP9 protein]		 CTD PMID:18429935 NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520 		JBrowse link
G Mpo myeloperoxidase multiple interactions
increases activity
increases expression		 EXP adelmidrol inhibits the reaction [Carrageenan results in increased activity of MPO protein]; arvelexin analog inhibits the reaction [Carrageenan results in increased expression of MPO protein]; Carrageenan inhibits the reaction [Raloxifene Hydrochloride results in increased activity of MPO protein]; Dexamethasone inhibits the reaction [Carrageenan results in increased activity of MPO protein]; Diclofenac inhibits the reaction [Carrageenan results in increased activity of MPO protein]; Ibuprofen inhibits the reaction [Carrageenan results in increased expression of MPO protein]; manganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Carrageenan results in increased activity of MPO protein]; N-(2-hydroxybenzoyl)tyramine inhibits the reaction [Carrageenan results in increased activity of MPO protein]; Thiazolidines analog inhibits the reaction [Carrageenan results in increased activity of MPO protein] CTD PMID:9890637 PMID:15860553 PMID:18429935 PMID:23872256 PMID:24412305 PMID:25451575 NCBI chr10:75,087,892...75,098,260
Ensembl chr10:75,087,892...75,098,260 		JBrowse link
G Mt1 metallothionein 1 multiple interactions ISO [Methylnitrosourea co-treated with Carrageenan] results in increased expression of MT1 protein CTD PMID:15928667 NCBI chr19:11,301,991...11,303,007
Ensembl chr17:78,793,336...78,793,724 		JBrowse link
G Nfe2l2 nuclear factor, erythroid 2-like 2 affects localization
multiple interactions		 EXP Carrageenan affects the localization of NFE2L2 protein
procyanidin B2 inhibits the reaction [Carrageenan affects the localization of NFE2L2 protein]		 CTD PMID:28844677 NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996 		JBrowse link
G Nfkbia NFKB inhibitor alpha multiple interactions ISO NFKBIA protein inhibits the reaction [Carrageenan results in increased expression of EGR1 protein] CTD PMID:22561171 NCBI chr 6:76,267,227...76,270,457
Ensembl chr 6:76,267,228...76,270,457 		JBrowse link
G Ngf nerve growth factor increases expression
multiple interactions		 EXP Carrageenan results in increased expression of NGF protein
Dexamethasone inhibits the reaction [Carrageenan results in increased expression of NGF protein]		 CTD PMID:10653021 NCBI chr 2:204,886,158...204,939,523
Ensembl chr 2:204,886,202...204,940,453 		JBrowse link
G Nos2 nitric oxide synthase 2 multiple interactions
increases expression
increases activity		 EXP
ISO		 adelmidrol inhibits the reaction [Carrageenan results in increased expression of NOS2 protein]; Carrageenan inhibits the reaction [Raloxifene Hydrochloride results in increased expression of NOS2 protein]; Carrageenan promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; Dexamethasone inhibits the reaction [Carrageenan results in increased expression of NOS2 mRNA]; Dexamethasone inhibits the reaction [Carrageenan results in increased expression of NOS2 protein]; Fluvoxamine inhibits the reaction [Carrageenan results in increased expression of NOS2 mRNA]
fucoxanthin inhibits the reaction [Carrageenan results in increased expression of NOS2 protein]; Indomethacin inhibits the reaction [Carrageenan results in increased expression of NOS2 protein]
Carrageenan results in increased activity of NOS2 protein
Carrageenan results in increased expression of NOS2 mRNA; Carrageenan results in increased expression of NOS2 protein		 CTD PMID:7542281 PMID:9890637 PMID:15860553 PMID:18429935 PMID:22330755 PMID:26418808 PMID:27803785 NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190 		JBrowse link
G Nqo1 NAD(P)H quinone dehydrogenase 1 decreases expression
multiple interactions		 EXP Carrageenan results in decreased expression of NQO1 protein
procyanidin B2 inhibits the reaction [Carrageenan results in decreased expression of NQO1 protein]		 CTD PMID:28844677 NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180 		JBrowse link
G Oprm1 opioid receptor, mu 1 decreases expression ISO Carrageenan results in decreased expression of OPRM1 protein CTD PMID:30763598 NCBI chr 1:43,454,803...43,704,948
Ensembl chr 1:43,454,803...43,704,948 		JBrowse link
G P2rx7 purinergic receptor P2X 7 multiple interactions EXP [(N-(1-(((cyanoimino)(5-quinolinylamino) methyl) amino)-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide) binds to and results in decreased activity of P2RX7 protein] which results in decreased susceptibility to Carrageenan CTD PMID:16982702 NCBI chr12:39,353,613...39,396,042
Ensembl chr12:39,353,613...39,396,042 		JBrowse link
G Pecam1 platelet and endothelial cell adhesion molecule 1 increases expression
multiple interactions		 EXP Carrageenan results in increased expression of PECAM1 protein
adelmidrol inhibits the reaction [Carrageenan results in increased expression of PECAM1 protein]		 CTD PMID:18429935 NCBI chr10:94,850,971...94,913,202 JBrowse link
G Ptges prostaglandin E synthase multiple interactions
increases expression		 EXP arvelexin analog inhibits the reaction [Carrageenan results in increased expression of PTGES protein] CTD PMID:17258197 PMID:25451575 NCBI chr 3:9,727,408...9,738,752
Ensembl chr 3:9,727,408...9,738,752 		JBrowse link
G Ptges2 prostaglandin E synthase 2 multiple interactions
increases activity		 EXP 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid inhibits the reaction [[Carrageenan results in increased activity of PTGES2 protein] which results in increased chemical synthesis of Dinoprostone]; [Carrageenan results in increased activity of PTGES2 protein] which results in increased chemical synthesis of Dinoprostone CTD PMID:19934399 NCBI chr 3:11,424,195...11,431,379
Ensembl chr 3:11,424,099...11,431,402 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions
increases expression		 EXP
ISO		 3-methylquercetin inhibits the reaction [Carrageenan results in increased expression of PTGS2 protein]; Carrageenan inhibits the reaction [Raloxifene Hydrochloride results in increased expression of PTGS2 protein]; Dexamethasone inhibits the reaction [Carrageenan results in increased expression of PTGS2 mRNA]; dragon's blood inhibits the reaction [Carrageenan results in increased expression of PTGS2 protein]; Fluvoxamine inhibits the reaction [Carrageenan results in increased expression of PTGS2 mRNA]; isoquercitrin inhibits the reaction [Carrageenan results in increased expression of PTGS2 mRNA]; Ketorolac inhibits the reaction [N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [Carrageenan results in increased expression of PTGS2 protein]]; N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [Carrageenan results in increased expression of PTGS2 protein]; nimesulide promotes the reaction [Carrageenan results in increased expression of PTGS2 protein]; Quercetin inhibits the reaction [Carrageenan results in increased expression of PTGS2 mRNA]; resveratrol inhibits the reaction [Carrageenan results in increased expression of PTGS2 mRNA]; Thioctic Acid inhibits the reaction [Carrageenan results in increased expression of PTGS2 mRNA]; triflusal inhibits the reaction [Carrageenan results in increased expression of PTGS2 protein]
fucoxanthin inhibits the reaction [Carrageenan results in increased expression of PTGS2 protein]; Indomethacin inhibits the reaction [Carrageenan results in increased expression of PTGS2 protein]
Carrageenan results in increased expression of PTGS2 mRNA; Carrageenan results in increased expression of PTGS2 protein		 CTD PMID:10101034 PMID:14654164 PMID:15860553 PMID:17258197 PMID:18814970 PMID:19735303 PMID:22198006 PMID:24337631 PMID:26418808 PMID:27803785 NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335 		JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit increases phosphorylation
increases localization
multiple interactions		 ISO
EXP		 Carrageenan results in increased phosphorylation of RELA protein
Carrageenan results in increased localization of RELA protein
IMMLG5521 inhibits the reaction [Carrageenan results in increased localization of RELA protein]		 CTD PMID:21549112 PMID:22561171 NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249 		JBrowse link
G Selp selectin P increases expression
multiple interactions		 EXP
ISO		 Carrageenan results in increased expression of SELP protein
IL1R1 protein promotes the reaction [Carrageenan results in increased expression of SELP protein]; PEGylated soluble tumor necrosis factor receptor I inhibits the reaction [Carrageenan results in increased expression of SELP protein]; TNFSF8 protein promotes the reaction [Carrageenan results in increased expression of SELP protein]
imisopasem manganese inhibits the reaction [Carrageenan results in increased expression of SELP protein]		 CTD PMID:11181422 PMID:15380531 NCBI chr13:82,428,914...82,464,629
Ensembl chr13:82,429,063...82,464,628 		JBrowse link
G Sstr4 somatostatin receptor 4 decreases response to substance ISO SSTR4 results in decreased susceptibility to Carrageenan CTD PMID:19622729 NCBI chr 3:142,739,781...142,741,644
Ensembl chr 3:142,739,781...142,741,644 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 increases secretion ISO Carrageenan results in increased secretion of TGFB1 protein CTD PMID:16368644 NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199 		JBrowse link
G Tjp1 tight junction protein 1 multiple interactions ISO 3-(4-methylphenylsulfonyl)-2-propenenitrile promotes the reaction [Carrageenan results in decreased expression of and affects the localization of TJP1 protein]; Carrageenan results in decreased expression of and affects the localization of TJP1 protein; EGR1 protein inhibits the reaction [Carrageenan results in decreased expression of and affects the localization of TJP1 protein] CTD PMID:22561171 NCBI chr 1:126,146,489...126,515,359
Ensembl chr 1:126,146,489...126,227,469 		JBrowse link
G Tnf tumor necrosis factor increases secretion
multiple interactions
increases expression		 ISO
EXP		 Carrageenan results in increased secretion of TNF protein
3-methylquercetin inhibits the reaction [Carrageenan results in increased expression of TNF protein]; adelmidrol inhibits the reaction [Carrageenan results in increased expression of TNF protein]; budlein A inhibits the reaction [Carrageenan results in increased secretion of TNF protein]; Dexamethasone inhibits the reaction [Carrageenan results in increased expression of TNF protein]; imisopasem manganese inhibits the reaction [Carrageenan results in increased expression of TNF protein]; IMMLG5521 inhibits the reaction [Carrageenan results in increased secretion of TNF protein]; isoquercitrin inhibits the reaction [Carrageenan results in increased expression of TNF protein]; N-(2-hydroxybenzoyl)tyramine inhibits the reaction [Carrageenan results in increased expression of TNF protein]; procyanidin B2 inhibits the reaction [Carrageenan results in increased expression of TNF protein]; Quercetin inhibits the reaction [Carrageenan results in increased expression of TNF protein]; Rutin inhibits the reaction [Carrageenan results in increased expression of TNF protein]; Thiazolidines analog inhibits the reaction [Carrageenan results in increased expression of TNF protein]
5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid inhibits the reaction [Carrageenan results in increased expression of TNF protein]; IL1R1 protein promotes the reaction [Carrageenan results in increased expression of TNF protein]; indole-3-guanylhydrazone hydrochloride inhibits the reaction [Carrageenan results in increased secretion of TNF protein]; Indomethacin inhibits the reaction [Carrageenan results in increased secretion of TNF protein]; PEGylated soluble tumor necrosis factor receptor I inhibits the reaction [Carrageenan results in increased expression of TNF protein]; TNFSF8 protein promotes the reaction [Carrageenan results in increased expression of TNF protein]		 CTD PMID:11181422 PMID:12444156 PMID:14654164 PMID:15380531 PMID:16368644 PMID:17320857 PMID:18429935 PMID:20383154 PMID:21549112 PMID:22330755 PMID:23774260 PMID:23872256 PMID:24412305 PMID:28844677 PMID:29499192 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000 		JBrowse link
G Tnfrsf8 TNF receptor superfamily member 8 multiple interactions
increases expression		 ISO IL1R1 protein promotes the reaction [Carrageenan results in increased expression of TNFRSF8 protein]; TNFSF8 protein promotes the reaction [Carrageenan results in increased expression of TNFRSF8 protein] CTD PMID:15380531 NCBI chr 5:163,186,349...163,231,578
Ensembl chr 5:163,186,349...163,231,578 		JBrowse link
G Tnfsf8 TNF superfamily member 8 increases expression
multiple interactions
increases response to substance		 ISO Carrageenan results in increased expression of TNFSF8 protein
IL1R1 protein promotes the reaction [Carrageenan results in increased expression of TNFSF8 protein]; TNFSF8 protein promotes the reaction [Carrageenan results in increased expression of ICAM1 protein]; TNFSF8 protein promotes the reaction [Carrageenan results in increased expression of SELP protein]; TNFSF8 protein promotes the reaction [Carrageenan results in increased expression of TNF protein]; TNFSF8 protein promotes the reaction [Carrageenan results in increased expression of TNFRSF8 protein]; TNFSF8 protein promotes the reaction [Carrageenan results in increased expression of TNFSF8 protein]
TNFSF8 protein results in increased susceptibility to Carrageenan		 CTD PMID:15380531 NCBI chr 5:79,664,779...79,691,547
Ensembl chr 5:79,664,765...79,691,258 		JBrowse link
G Vcam1 vascular cell adhesion molecule 1 increases expression
multiple interactions		 EXP Carrageenan results in increased expression of VCAM1 mRNA
Dexamethasone inhibits the reaction [Carrageenan results in increased expression of VCAM1 mRNA]; Fluvoxamine inhibits the reaction [Carrageenan results in increased expression of VCAM1 mRNA]		 CTD PMID:27803785 NCBI chr 2:219,071,193...219,090,931
Ensembl chr 2:219,071,193...219,097,619 		JBrowse link
dextran term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Il10 interleukin 10 multiple interactions ISO [Dextrans co-treated with ferrite analog] results in increased expression of IL10 mRNA CTD PMID:26576301 NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392 		JBrowse link
G Irak1 interleukin-1 receptor-associated kinase 1 multiple interactions ISO [Dextrans co-treated with ferrite analog] results in decreased expression of IRAK1 mRNA CTD PMID:26576301 NCBI chr  X:156,716,469...156,726,367
Ensembl chr  X:156,716,604...156,725,977 		JBrowse link
G Slc31a2 solute carrier family 31 member 2 decreases uptake ISO SLC31A2 protein results in decreased uptake of Dextrans CTD PMID:20930109 NCBI chr 5:78,120,606...78,131,111
Ensembl chr 5:78,120,607...78,131,114 		JBrowse link
G Tnfrsf1b TNF receptor superfamily member 1B multiple interactions ISO [Dextrans co-treated with ferrite analog] results in decreased expression of TNFRSF1B mRNA CTD PMID:26576301 NCBI chr 5:163,136,390...163,167,299
Ensembl chr 5:163,136,390...163,167,299 		JBrowse link
dextran sulfate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abat 4-aminobutyrate aminotransferase multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ABAT mRNA CTD PMID:29950665 NCBI chr10:7,093,406...7,200,439
Ensembl chr10:7,093,405...7,200,499 		JBrowse link
G Abca1 ATP binding cassette subfamily A member 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ABCA1 mRNA CTD PMID:29950665 NCBI chr 5:69,857,717...69,983,042
Ensembl chr 5:69,857,771...69,983,015 		JBrowse link
G Abcb11 ATP binding cassette subfamily B member 11 decreases expression ISO Dextran Sulfate results in decreased expression of ABCB11 mRNA; Dextran Sulfate results in decreased expression of ABCB11 protein CTD PMID:27580383 NCBI chr 3:55,480,024...55,587,946
Ensembl chr 3:55,480,024...55,587,946 		JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ABCB1A mRNA; ABCB1A protein affects the susceptibility to [Dextran Sulfate co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] CTD PMID:29950665 PMID:30701287 NCBI chr 4:22,339,829...22,517,642
Ensembl chr 4:22,133,521...22,425,515 		JBrowse link
G Abcb1b ATP-binding cassette, subfamily B (MDR/TAP), member 1B multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ABCB1B mRNA; ABCB1B protein affects the susceptibility to [Dextran Sulfate co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine] CTD PMID:29950665 PMID:30701287 NCBI chr 4:22,225,123...22,307,577
Ensembl chr 4:22,133,521...22,425,515 		JBrowse link
G Abcb4 ATP binding cassette subfamily B member 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ABCB4 mRNA CTD PMID:29950665 NCBI chr 4:22,133,984...22,192,687
Ensembl chr 4:22,133,521...22,425,515 		JBrowse link
G Abcb6 ATP binding cassette subfamily B member 6 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ABCB6 mRNA CTD PMID:29950665 NCBI chr 9:82,373,950...82,382,228
Ensembl chr 9:82,373,946...82,382,272 		JBrowse link
G Abcc10 ATP binding cassette subfamily C member 10 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ABCC10 mRNA CTD PMID:29950665 NCBI chr 9:17,041,351...17,061,263
Ensembl chr 9:17,041,389...17,063,780 		JBrowse link
G Abcc2 ATP binding cassette subfamily C member 2 decreases expression
multiple interactions
affects response to substance		 ISO Dextran Sulfate results in decreased expression of ABCC2 mRNA; Dextran Sulfate results in decreased expression of ABCC2 protein
ABCC2 protein affects the susceptibility to [Dextran Sulfate co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine]
ABCC2 protein affects the susceptibility to Dextran Sulfate		 CTD PMID:27580383 PMID:30701287 NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252 		JBrowse link
G Abcc3 ATP binding cassette subfamily C member 3 decreases expression
affects response to substance
multiple interactions		 ISO Dextran Sulfate results in decreased expression of ABCC3 mRNA; Dextran Sulfate results in decreased expression of ABCC3 protein
ABCC3 protein affects the susceptibility to Dextran Sulfate
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ABCC3 mRNA; ABCC3 protein affects the susceptibility to [Dextran Sulfate co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine]		 CTD PMID:27580383 PMID:29950665 PMID:30701287 NCBI chr10:82,047,308...82,116,928
Ensembl chr10:82,047,863...82,117,109 		JBrowse link
G Abcc4 ATP binding cassette subfamily C member 4 multiple interactions
decreases expression		 ISO [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of ABCC4 mRNA; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ABCC4 mRNA
Dextran Sulfate results in decreased expression of ABCC4 mRNA; Dextran Sulfate results in decreased expression of ABCC4 protein		 CTD PMID:26271895 PMID:27580383 PMID:29950665 NCBI chr15:103,695,415...103,927,980
Ensembl chr15:103,696,557...103,927,592 		JBrowse link
G Abcc5 ATP binding cassette subfamily C member 5 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ABCC5 mRNA CTD PMID:29950665 NCBI chr11:84,395,982...84,490,215
Ensembl chr11:84,396,033...84,490,211 		JBrowse link
G Abcc6 ATP binding cassette subfamily C member 6 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ABCC6 mRNA CTD PMID:29950665 NCBI chr 1:101,954,786...102,013,252
Ensembl chr 1:101,959,540...102,013,243 		JBrowse link
G Abcc9 ATP binding cassette subfamily C member 9 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ABCC9 mRNA CTD PMID:29950665 NCBI chr 4:176,806,098...176,928,540
Ensembl chr 4:176,805,431...176,922,424 		JBrowse link
G Abcf2 ATP binding cassette subfamily F member 2 decreases expression
multiple interactions		 ISO Dextran Sulfate results in decreased expression of ABCF2 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ABCF2 protein]		 CTD PMID:32272095 NCBI chr 4:7,122,850...7,135,607
Ensembl chr 4:7,122,890...7,135,669 		JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ABCG1 mRNA CTD PMID:29950665 NCBI chr20:9,743,269...9,842,735
Ensembl chr20:9,743,269...9,840,489 		JBrowse link
G Abcg2 ATP binding cassette subfamily G member 2 multiple interactions
affects response to substance		 ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ABCG2 mRNA; ABCG2 protein affects the susceptibility to [Dextran Sulfate co-treated with 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine]
ABCG2 protein affects the susceptibility to Dextran Sulfate		 CTD PMID:29950665 PMID:30701287 NCBI chr 4:88,765,441...88,890,268
Ensembl chr 4:88,832,178...88,890,621 		JBrowse link
G Abi1 abl-interactor 1 multiple interactions
decreases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ABI1 protein] CTD PMID:32272095 NCBI chr17:89,951,662...90,033,334
Ensembl chr17:89,951,752...90,033,328 		JBrowse link
G Acaa1a acetyl-CoA acyltransferase 1A multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACAA1A mRNA CTD PMID:29950665 NCBI chr 8:128,027,880...128,036,471
Ensembl chr 8:128,027,958...128,036,236 		JBrowse link
G Acaa1b acetyl-Coenzyme A acyltransferase 1B multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACAA1B mRNA CTD PMID:29950665 NCBI chr 8:127,836,235...127,845,296 JBrowse link
G Acaa2 acetyl-CoA acyltransferase 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACAA2 mRNA CTD PMID:29950665 NCBI chr18:70,733,872...70,762,395
Ensembl chr18:70,733,872...70,762,395 		JBrowse link
G Acaca acetyl-CoA carboxylase alpha multiple interactions
increases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in increased expression of ACACA protein] CTD PMID:32272095 NCBI chr10:71,519,392...71,719,910
Ensembl chr10:71,536,533...71,719,910 		JBrowse link
G Acads acyl-CoA dehydrogenase short chain multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACADS mRNA CTD PMID:29950665 NCBI chr12:47,254,503...47,263,747
Ensembl chr12:47,254,484...47,263,747 		JBrowse link
G Acadsb acyl-CoA dehydrogenase, short/branched chain multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACADSB mRNA CTD PMID:29950665 NCBI chr 1:201,981,362...202,022,771
Ensembl chr 1:201,981,357...202,021,008 		JBrowse link
G Ace angiotensin I converting enzyme multiple interactions
increases abundance		 ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ACE mRNA
dextran sodium sulfate increases abundance of Ace protein in small and large intestine extracellular space		 CTD PMID:29950665, PMID:26401072 RGD:11555935 NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822 		JBrowse link
G Ache acetylcholinesterase multiple interactions
decreases activity		 ISO [Chlorpyrifos co-treated with Dextran Sulfate] results in decreased activity of ACHE protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ACHE mRNA
Dextran Sulfate results in decreased activity of ACHE protein		 CTD PMID:29950665 PMID:31226429 PMID:31807802 NCBI chr12:22,472,358...22,477,052
Ensembl chr12:22,472,358...22,478,753 		JBrowse link
G Ackr1 atypical chemokine receptor 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ACKR1 mRNA CTD PMID:29950665 NCBI chr13:91,827,310...91,828,875 JBrowse link
G Ackr2 atypical chemokine receptor 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ACKR2 mRNA CTD PMID:29950665 NCBI chr 8:130,526,521...130,543,566
Ensembl chr 8:130,538,651...130,542,227 		JBrowse link
G Ackr3 atypical chemokine receptor 3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ACKR3 mRNA CTD PMID:29950665 NCBI chr 9:97,355,881...97,367,455
Ensembl chr 9:97,355,924...97,367,445 		JBrowse link
G Ackr4 atypical chemokine receptor 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACKR4 mRNA CTD PMID:29950665 NCBI chr 8:112,643,838...112,651,668
Ensembl chr 8:112,644,222...112,648,880 		JBrowse link
G Acsbg2 acyl-CoA synthetase bubblegum family member 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACSBG2 mRNA CTD PMID:29950665 NCBI chr 9:10,172,317...10,203,550
Ensembl chr 9:10,172,832...10,203,460 		JBrowse link
G Acsm1 acyl-CoA synthetase medium-chain family member 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ACSM1 mRNA CTD PMID:29950665 NCBI chr 1:189,359,374...189,395,277
Ensembl chr 1:189,289,957...189,395,276 		JBrowse link
G Acsm3 acyl-CoA synthetase medium-chain family member 3 decreases expression
multiple interactions		 ISO Dextran Sulfate results in decreased expression of ACSM3 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ACSM3 protein]		 CTD PMID:32272095 NCBI chr 1:189,514,504...189,541,233
Ensembl chr 1:189,514,553...189,541,224 		JBrowse link
G Acss1 acyl-CoA synthetase short-chain family member 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACSS1 mRNA CTD PMID:29950665 NCBI chr 3:146,420,346...146,470,293
Ensembl chr 3:146,420,346...146,470,293 		JBrowse link
G Acss2 acyl-CoA synthetase short-chain family member 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ACSS2 mRNA CTD PMID:29950665 NCBI chr 3:151,032,925...151,075,856
Ensembl chr 3:151,032,952...151,075,856 		JBrowse link
G Actl6a actin-like 6A multiple interactions
decreases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ACTL6A protein] CTD PMID:32272095 NCBI chr 2:119,112,776...119,128,870
Ensembl chr 2:119,112,513...119,129,751 		JBrowse link
G Actn1 actinin, alpha 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ACTN1 mRNA CTD PMID:29950665 NCBI chr 6:103,376,557...103,470,497
Ensembl chr 6:103,375,799...103,470,555 		JBrowse link
G Actn2 actinin alpha 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ACTN2 mRNA CTD PMID:29950665 NCBI chr17:66,304,530...66,397,647
Ensembl chr17:66,304,501...66,397,653 		JBrowse link
G Acvr1 activin A receptor type 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ACVR1 mRNA CTD PMID:29950665 NCBI chr 3:44,432,476...44,539,680
Ensembl chr 3:44,432,471...44,522,930 		JBrowse link
G Ada adenosine deaminase increases expression
multiple interactions		 ISO Dextran Sulfate results in increased expression of ADA protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of ADA protein]		 CTD PMID:32272095 NCBI chr 3:160,115,840...160,139,947
Ensembl chr 3:160,115,842...160,139,947 		JBrowse link
G Adam17 ADAM metallopeptidase domain 17 multiple interactions
increases expression
affects response to substance		 ISO ADAM17 protein affects the reaction [Dextran Sulfate results in decreased expression of SIRT1 mRNA]; ADAM17 protein affects the reaction [Dextran Sulfate results in decreased expression of TIMP3 mRNA]; ADAM17 protein affects the reaction [Dextran Sulfate results in increased expression of IFNG protein]; ADAM17 protein affects the reaction [Dextran Sulfate results in increased expression of IL17A protein]; ADAM17 protein affects the reaction [Dextran Sulfate results in increased expression of IL1B protein]; ADAM17 protein affects the reaction [Dextran Sulfate results in increased expression of IL6 protein]; ADAM17 protein affects the reaction [Dextran Sulfate results in increased expression of TNF protein]; resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of ADAM17 mRNA]
ADAM17 protein affects the susceptibility to Dextran Sulfate		 CTD PMID:24548422 NCBI chr 6:43,400,525...43,448,280
Ensembl chr 6:43,400,528...43,448,280 		JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADAMTS1 mRNA CTD PMID:29950665 NCBI chr11:25,342,119...25,350,938
Ensembl chr11:25,342,126...25,350,974 		JBrowse link
G Adamts14 ADAM metallopeptidase with thrombospondin type 1 motif, 14 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADAMTS14 mRNA CTD PMID:29950665 NCBI chr20:30,812,319...30,888,936
Ensembl chr20:30,812,353...30,888,751 		JBrowse link
G Adamts2 ADAM metallopeptidase with thrombospondin type 1 motif, 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADAMTS2 mRNA CTD PMID:29950665 NCBI chr10:36,098,051...36,304,416
Ensembl chr10:36,098,051...36,304,409 		JBrowse link
G Adamts4 ADAM metallopeptidase with thrombospondin type 1 motif, 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADAMTS4 mRNA CTD PMID:29950665 NCBI chr13:89,622,996...89,632,485
Ensembl chr13:89,622,632...89,634,419 		JBrowse link
G Adamts5 ADAM metallopeptidase with thrombospondin type 1 motif, 5 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADAMTS5 mRNA CTD PMID:29950665 NCBI chr11:25,411,174...25,456,639
Ensembl chr11:25,410,975...25,456,836 		JBrowse link
G Adcy2 adenylate cyclase 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADCY2 mRNA CTD PMID:29950665 NCBI chr 1:37,043,071...37,698,390
Ensembl chr 1:37,507,276...37,698,390 		JBrowse link
G Adcy4 adenylate cyclase 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADCY4 mRNA CTD PMID:29950665 NCBI chr15:34,453,917...34,469,779
Ensembl chr15:34,453,915...34,469,746 		JBrowse link
G Adcy6 adenylate cyclase 6 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADCY6 mRNA CTD PMID:29950665 NCBI chr 7:140,270,678...140,291,722
Ensembl chr 7:140,270,692...140,291,620 		JBrowse link
G Adcy7 adenylate cyclase 7 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADCY7 mRNA CTD PMID:29950665 NCBI chr19:19,702,307...19,762,973
Ensembl chr19:19,704,859...19,727,081 		JBrowse link
G Adcyap1 adenylate cyclase activating polypeptide 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADCYAP1 mRNA CTD PMID:29950665 NCBI chr 9:121,705,897...121,725,736
Ensembl chr 9:121,706,979...121,725,716 		JBrowse link
G Adcyap1r1 ADCYAP receptor type I multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADCYAP1R1 mRNA CTD PMID:29950665 NCBI chr 4:85,662,809...85,711,696
Ensembl chr 4:85,662,892...85,711,696 		JBrowse link
G Adgra2 adhesion G protein-coupled receptor A2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADGRA2 mRNA CTD PMID:29950665 NCBI chr16:69,094,587...69,133,015
Ensembl chr16:69,095,936...69,132,584 		JBrowse link
G Adgrb1 adhesion G protein-coupled receptor B1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADGRB1 mRNA CTD PMID:29950665 NCBI chr 7:115,766,484...115,828,514 JBrowse link
G Adgre5 adhesion G protein-coupled receptor E5 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADGRE5 mRNA CTD PMID:29950665 NCBI chr19:24,854,981...24,875,712
Ensembl chr19:24,855,299...24,875,137 		JBrowse link
G Adgrf1 adhesion G protein-coupled receptor F1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADGRF1 mRNA CTD PMID:29950665 NCBI chr 9:20,343,730...20,378,686 JBrowse link
G Adgrf5 adhesion G protein-coupled receptor F5 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADGRF5 mRNA CTD PMID:29950665 NCBI chr 9:20,091,121...20,195,706
Ensembl chr 9:20,091,099...20,195,566 		JBrowse link
G Adh1 alcohol dehydrogenase 1 (class I) multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADH1 mRNA CTD PMID:29950665 NCBI chr 2:243,550,655...243,562,243
Ensembl chr 2:243,550,627...243,687,857 		JBrowse link
G Adh5 alcohol dehydrogenase 5 (class III), chi polypeptide multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADH5 mRNA CTD PMID:29950665 NCBI chr 2:243,728,500...243,740,907
Ensembl chr 2:243,700,784...243,740,899 		JBrowse link
G Adm adrenomedullin multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADM mRNA CTD PMID:29950665 NCBI chr 1:175,443,189...175,447,260
Ensembl chr 1:175,445,088...175,447,259 		JBrowse link
G Adora2a adenosine A2a receptor multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADORA2A mRNA CTD PMID:29950665 NCBI chr20:14,265,251...14,282,873
Ensembl chr20:14,265,252...14,282,873 		JBrowse link
G Adora2b adenosine A2B receptor multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of ADORA2B mRNA CTD PMID:29950665 NCBI chr10:48,569,563...48,586,366
Ensembl chr10:48,569,555...48,586,365 		JBrowse link
G Adora3 adenosine A3 receptor multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADORA3 mRNA CTD PMID:29950665 NCBI chr 2:208,336,909...208,379,217
Ensembl chr 2:208,373,154...208,376,803 		JBrowse link
G Adra2a adrenoceptor alpha 2A multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ADRA2A mRNA CTD PMID:29950665 NCBI chr 1:274,766,283...274,769,083
Ensembl chr 1:274,766,283...274,769,081 		JBrowse link
G Adrb2 adrenoceptor beta 2 multiple interactions ISO [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of ADRB2 mRNA; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ADRB2 mRNA CTD PMID:26271895 PMID:29950665 NCBI chr18:57,513,792...57,515,834
Ensembl chr18:57,513,793...57,515,834 		JBrowse link
G Agt angiotensinogen multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AGT mRNA CTD PMID:29950665 NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433 		JBrowse link
G Akap12 A-kinase anchoring protein 12 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AKAP12 mRNA CTD PMID:29950665 NCBI chr 1:40,816,130...40,906,582
Ensembl chr 1:40,816,107...40,906,581 		JBrowse link
G Akap5 A-kinase anchoring protein 5 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AKAP5 mRNA CTD PMID:29950665 NCBI chr 6:99,356,509...99,361,909
Ensembl chr 6:99,356,509...99,361,909 		JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AKR1B3 mRNA CTD PMID:29950665 NCBI chr 4:61,706,866...61,720,959
Ensembl chr 4:61,706,864...61,720,956 		JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of AKR1C18 mRNA CTD PMID:29950665 NCBI chr17:69,761,126...69,778,021
Ensembl chr17:69,761,118...69,778,021 		JBrowse link
G Akt1 AKT serine/threonine kinase 1 multiple interactions ISO [APC protein affects the susceptibility to Dextran Sulfate] which results in increased phosphorylation of AKT1 protein; resorcinol inhibits the reaction [[APC protein affects the susceptibility to Dextran Sulfate] which results in increased phosphorylation of AKT1 protein] CTD PMID:26262998 NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258 		JBrowse link
G Alb albumin multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ALB mRNA CTD PMID:29950665 NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863 		JBrowse link
G Aldh1a1 aldehyde dehydrogenase 1 family, member A1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ALDH1A1 mRNA CTD PMID:29950665 NCBI chr 1:238,222,689...238,264,381
Ensembl chr 1:238,222,521...238,264,330 		JBrowse link
G Aldh1b1 aldehyde dehydrogenase 1 family, member B1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ALDH1B1 mRNA CTD PMID:29950665 NCBI chr 5:61,382,351...61,387,359
Ensembl chr 5:61,382,351...61,387,358 		JBrowse link
G Aldh2 aldehyde dehydrogenase 2 family member multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ALDH2 mRNA CTD PMID:29950665 NCBI chr12:40,466,418...40,498,813
Ensembl chr12:40,466,495...40,498,752 		JBrowse link
G Aldh3a2 aldehyde dehydrogenase 3 family, member A2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ALDH3A2 mRNA CTD PMID:29950665 NCBI chr10:47,525,486...47,546,535
Ensembl chr10:47,525,493...47,546,345 		JBrowse link
G Aldh7a1 aldehyde dehydrogenase 7 family, member A1 multiple interactions
increases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in increased expression of ALDH7A1 protein] CTD PMID:32272095 NCBI chr18:51,619,007...51,651,267
Ensembl chr18:51,619,007...51,651,267 		JBrowse link
G Alox12b arachidonate 12-lipoxygenase, 12R type multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ALOX12B mRNA CTD PMID:29950665 NCBI chr10:55,744,646...55,756,524
Ensembl chr10:55,744,588...55,756,566 		JBrowse link
G Alox5 arachidonate 5-lipoxygenase multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ALOX5 mRNA CTD PMID:29950665 NCBI chr 4:148,398,004...148,446,308
Ensembl chr 4:148,398,892...148,446,303 		JBrowse link
G Alox5ap arachidonate 5-lipoxygenase activating protein multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ALOX5AP mRNA CTD PMID:29950665 NCBI chr12:6,854,930...6,879,112
Ensembl chr12:6,854,920...6,879,154 		JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ALPL mRNA CTD PMID:29950665 NCBI chr 5:156,086,496...156,141,513
Ensembl chr 5:156,086,497...156,141,537 		JBrowse link
G Angpt4 angiopoietin 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ANGPT4 mRNA CTD PMID:29950665 NCBI chr 3:147,421,724...147,455,670
Ensembl chr 3:147,422,095...147,455,670 		JBrowse link
G Ano1 anoctamin 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ANO1 mRNA CTD PMID:29950665 NCBI chr 1:217,754,349...217,902,540
Ensembl chr 1:217,754,336...217,902,473 		JBrowse link
G Ano10 anoctamin 10 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ANO10 mRNA CTD PMID:29950665 NCBI chr 8:130,812,941...130,931,021
Ensembl chr 8:130,813,214...130,930,990 		JBrowse link
G Ano6 anoctamin 6 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ANO6 mRNA CTD PMID:29950665 NCBI chr 7:137,142,063...137,335,208
Ensembl chr 7:137,142,170...137,335,208 		JBrowse link
G Ano7 anoctamin 7 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ANO7 mRNA CTD PMID:29950665 NCBI chr 9:100,511,610...100,551,798
Ensembl chr 9:100,511,610...100,551,798 		JBrowse link
G Ano9 anoctamin 9 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ANO9 mRNA CTD PMID:29950665 NCBI chr 1:213,908,389...213,929,291
Ensembl chr 1:213,908,982...213,921,208 		JBrowse link
G Anos1 anosmin 1 increases expression ISO Dextran Sulfate results in increased expression of WFDC17 mRNA CTD PMID:23894361 Ensembl chr10:70,999,780...71,000,627 JBrowse link
G Anxa1 annexin A1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ANXA1 mRNA CTD PMID:29950665 NCBI chr 1:237,893,983...237,910,002
Ensembl chr 1:237,893,966...237,910,012 		JBrowse link
G Anxa4 annexin A4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ANXA4 mRNA CTD PMID:29950665 NCBI chr 4:118,538,775...118,595,591
Ensembl chr 4:118,538,777...118,595,580 		JBrowse link
G Ap1m1 adaptor related protein complex 1 subunit mu 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AP1M1 mRNA CTD PMID:29950665 NCBI chr16:19,288,354...19,303,818
Ensembl chr16:19,288,355...19,303,824 		JBrowse link
G Ap1s1 adaptor related protein complex 1 subunit sigma 1 decreases expression
multiple interactions		 ISO Dextran Sulfate results in decreased expression of AP1S1 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of AP1S1 protein]		 CTD PMID:32272095 NCBI chr12:22,665,128...22,676,079
Ensembl chr12:22,665,112...22,676,075 		JBrowse link
G Apc APC regulator of WNT signaling pathway affects response to substance
multiple interactions		 ISO APC affects the susceptibility to Dextran Sulfate; APC protein affects the susceptibility to Dextran Sulfate
[APC protein affects the susceptibility to Dextran Sulfate] which affects the activity of MPO protein; [APC protein affects the susceptibility to Dextran Sulfate] which results in increased chemical synthesis of PTEN protein modified form; [APC protein affects the susceptibility to Dextran Sulfate] which results in increased phosphorylation of AKT1 protein; PDE4B protein affects the reaction [APC protein affects the susceptibility to Dextran Sulfate]; resorcinol inhibits the reaction [[APC protein affects the susceptibility to Dextran Sulfate] which affects the activity of MPO protein]; resorcinol inhibits the reaction [[APC protein affects the susceptibility to Dextran Sulfate] which results in increased chemical synthesis of PTEN protein modified form]; resorcinol inhibits the reaction [[APC protein affects the susceptibility to Dextran Sulfate] which results in increased phosphorylation of AKT1 protein]		 CTD PMID:16049979 PMID:26262998 PMID:30188895 NCBI chr18:27,011,710...27,106,323
Ensembl chr18:27,047,382...27,105,531 		JBrowse link
G Apln apelin multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of APLN mRNA CTD PMID:29950665 NCBI chr  X:134,856,719...134,866,210
Ensembl chr  X:134,856,726...134,866,210 		JBrowse link
G Apoa4 apolipoprotein A4 decreases expression
multiple interactions		 ISO Dextran Sulfate results in decreased expression of APOA4 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of APOA4 protein]		 CTD PMID:32272095 NCBI chr 8:50,536,983...50,539,371
Ensembl chr 8:50,537,009...50,539,376 		JBrowse link
G Apob apolipoprotein B multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of APOB mRNA CTD PMID:29950665 NCBI chr 6:33,176,826...33,216,381
Ensembl chr 6:33,176,778...33,224,997 		JBrowse link
G Apoe apolipoprotein E increases expression
multiple interactions		 ISO Dextran Sulfate results in increased expression of APOE protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of APOE protein]		 CTD PMID:32272095 NCBI chr 1:80,612,894...80,616,820
Ensembl chr 1:80,612,895...80,617,057 		JBrowse link
G App amyloid beta precursor protein multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of APP mRNA CTD PMID:29950665 NCBI chr11:24,425,013...24,641,872
Ensembl chr11:24,425,005...24,641,858 		JBrowse link
G Aqp1 aquaporin 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of AQP1 mRNA CTD PMID:29950665 NCBI chr 4:85,551,503...85,563,683
Ensembl chr 4:85,551,502...85,569,360 		JBrowse link
G Aqp11 aquaporin 11 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of AQP11 mRNA CTD PMID:29950665 NCBI chr 1:162,703,394...162,713,560
Ensembl chr 1:162,703,442...162,713,610 		JBrowse link
G Aqp2 aquaporin 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AQP2 mRNA CTD PMID:29950665 NCBI chr 7:141,237,802...141,242,837
Ensembl chr 7:141,237,768...141,245,165 		JBrowse link
G Aqp3 aquaporin 3 (Gill blood group) multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AQP3 mRNA CTD PMID:29950665 NCBI chr 5:57,423,735...57,429,252
Ensembl chr 5:57,423,734...57,429,245 		JBrowse link
G Aqp8 aquaporin 8 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of AQP8 mRNA CTD PMID:29950665 NCBI chr 1:193,424,818...193,430,665
Ensembl chr 1:193,424,812...193,430,676 		JBrowse link
G Aqp9 aquaporin 9 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AQP9 mRNA CTD PMID:29950665 NCBI chr 8:77,559,621...77,599,781
Ensembl chr 8:77,559,624...77,599,781 		JBrowse link
G Ar androgen receptor multiple interactions
increases expression		 ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AR mRNA
Dextran Sulfate results in increased expression of AR mRNA		 CTD PMID:27920257 PMID:29950665 NCBI chr  X:67,656,253...67,828,998
Ensembl chr  X:67,656,253...67,829,026 		JBrowse link
G Arg1 arginase 1 multiple interactions ISO [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARG1 mRNA; [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARG1 protein; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARG1 mRNA]; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARG1 protein] CTD PMID:25026504 NCBI chr 1:21,525,421...21,537,872
Ensembl chr 1:21,525,421...21,537,863 		JBrowse link
G Arhgap15 Rho GTPase activating protein 15 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ARHGAP15 mRNA CTD PMID:29950665 NCBI chr 3:28,626,987...29,236,225
Ensembl chr 3:28,627,084...29,236,219 		JBrowse link
G Arhgap20 Rho GTPase activating protein 20 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARHGAP20 mRNA CTD PMID:29950665 NCBI chr 8:56,179,581...56,264,343
Ensembl chr 8:56,179,637...56,264,263 		JBrowse link
G Arhgap25 Rho GTPase activating protein 25 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ARHGAP25 mRNA CTD PMID:29950665 NCBI chr 4:119,249,682...119,327,822
Ensembl chr 4:119,249,682...119,327,822 		JBrowse link
G Arhgap40 Rho GTPase activating protein 40 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARHGAP40 mRNA CTD PMID:29950665 NCBI chr 3:154,996,685...155,042,199
Ensembl chr 3:154,996,750...155,041,816 		JBrowse link
G Arhgdib Rho GDP dissociation inhibitor beta increases expression
multiple interactions		 ISO Dextran Sulfate results in increased expression of ARHGDIB mRNA
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ARHGDIB mRNA		 CTD PMID:23894361 PMID:29950665 NCBI chr 4:170,913,920...170,932,789
Ensembl chr 4:170,913,923...170,932,618 		JBrowse link
G Arhgef1 Rho guanine nucleotide exchange factor 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ARHGEF1 mRNA CTD PMID:29950665 NCBI chr 1:81,769,212...81,797,237
Ensembl chr 1:81,779,380...81,797,236 		JBrowse link
G Arhgef12 Rho guanine nucleotide exchange factor 12 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ARHGEF12 mRNA CTD PMID:29950665 NCBI chr 8:47,259,377...47,393,042
Ensembl chr 8:47,259,404...47,393,503 		JBrowse link
G Arhgef6 Rac/Cdc42 guanine nucleotide exchange factor 6 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ARHGEF6 mRNA CTD PMID:29950665 NCBI chr  X:159,722,031...159,841,344
Ensembl chr  X:159,723,866...159,841,072 		JBrowse link
G Arrb2 arrestin, beta 2 multiple interactions ISO [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of ARRB2 mRNA CTD PMID:26271895 NCBI chr10:57,040,252...57,048,045
Ensembl chr10:57,040,267...57,048,134 		JBrowse link
G Asb2 ankyrin repeat and SOCS box-containing 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ASB2 mRNA CTD PMID:29950665 NCBI chr 6:127,212,325...127,248,451
Ensembl chr 6:127,212,273...127,248,372 		JBrowse link
G Asic4 acid sensing ion channel subunit family member 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ASIC4 mRNA CTD PMID:29950665 NCBI chr 9:82,647,071...82,668,920
Ensembl chr 9:82,647,071...82,668,920 		JBrowse link
G Atg5 autophagy related 5 multiple interactions
increases expression		 ISO 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG5 mRNA]]; 6-formylindolo(3,2-b)carbazole promotes the reaction [Dextran Sulfate results in increased expression of ATG5 mRNA]; alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG5 mRNA]; ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]]; ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased secretion of IL1B protein]]; Leucine inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG5 mRNA]] CTD PMID:27611972 PMID:31676321 NCBI chr20:49,301,783...49,393,147
Ensembl chr20:49,318,308...49,393,140 		JBrowse link
G Atg7 autophagy related 7 multiple interactions
increases expression		 ISO 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]]; 6-formylindolo(3,2-b)carbazole promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]; alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]; Leucine inhibits the reaction [alpinetin promotes the reaction [Dextran Sulfate results in increased expression of ATG7 mRNA]] CTD PMID:31676321 NCBI chr 4:146,570,113...146,777,093
Ensembl chr 4:146,598,413...146,777,124 		JBrowse link
G Atp10a ATPase phospholipid transporting 10A (putative) multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP10A mRNA CTD PMID:29950665 NCBI chr 1:115,973,343...116,141,892
Ensembl chr 1:115,975,324...116,141,892 		JBrowse link
G Atp11b ATPase phospholipid transporting 11B (putative) multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP11B mRNA CTD PMID:29950665 NCBI chr 2:122,337,757...122,445,090
Ensembl chr 2:122,368,265...122,444,878 		JBrowse link
G Atp12a ATPase H+/K+ transporting non-gastric alpha2 subunit multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP12A mRNA CTD PMID:29950665 NCBI chr15:36,561,306...36,590,171
Ensembl chr15:36,565,495...36,590,171 		JBrowse link
G Atp1a1 ATPase Na+/K+ transporting subunit alpha 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP1A1 mRNA CTD PMID:29950665 NCBI chr 2:204,003,742...204,032,023
Ensembl chr 2:204,003,742...204,032,023 		JBrowse link
G Atp1a3 ATPase Na+/K+ transporting subunit alpha 3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP1A3 mRNA CTD PMID:29950665 NCBI chr 1:81,852,423...81,881,565
Ensembl chr 1:81,852,429...81,881,549 		JBrowse link
G Atp1a4 ATPase Na+/K+ transporting subunit alpha 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP1A4 mRNA CTD PMID:29950665 NCBI chr13:90,605,792...90,642,032
Ensembl chr13:90,605,794...90,641,772 		JBrowse link
G Atp1b1 ATPase Na+/K+ transporting subunit beta 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP1B1 mRNA CTD PMID:29950665 NCBI chr13:82,737,161...82,757,681
Ensembl chr13:82,737,159...82,758,004 		JBrowse link
G Atp1b3 ATPase Na+/K+ transporting subunit beta 3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP1B3 mRNA CTD PMID:29950665 NCBI chr 8:104,190,032...104,221,342
Ensembl chr 8:104,190,032...104,221,342 		JBrowse link
G Atp2a1 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP2A1 mRNA CTD PMID:29950665 NCBI chr 1:197,855,912...197,875,038 JBrowse link
G Atp2a3 ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP2A3 mRNA CTD PMID:29950665 NCBI chr10:59,528,849...59,560,440
Ensembl chr10:59,529,785...59,560,433 		JBrowse link
G Atp2b1 ATPase plasma membrane Ca2+ transporting 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP2B1 mRNA CTD PMID:29950665 NCBI chr 7:41,114,606...41,223,138
Ensembl chr 7:41,114,697...41,220,579 		JBrowse link
G Atp2c2 ATPase secretory pathway Ca2+ transporting 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of ATP2C2 mRNA CTD PMID:29950665 NCBI chr19:52,347,480...52,404,608
Ensembl chr19:52,347,580...52,404,607 		JBrowse link
G Atp4b ATPase H+/K+ transporting subunit beta multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP4B mRNA CTD PMID:29950665 NCBI chr16:81,136,218...81,145,131
Ensembl chr16:81,136,218...81,145,131 		JBrowse link
G Atp6v0a2 ATPase H+ transporting V0 subunit a2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP6V0A2 mRNA CTD PMID:29950665 NCBI chr12:37,368,321...37,398,233
Ensembl chr12:37,363,906...37,425,596 		JBrowse link
G Atp6v0a4 ATPase H+ transporting V0 subunit a4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP6V0A4 mRNA CTD PMID:29950665 NCBI chr 4:65,736,585...65,821,916
Ensembl chr 4:65,736,585...65,818,521 		JBrowse link
G Atp6v0d2 ATPase H+ transporting V0 subunit D2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP6V0D2 mRNA CTD PMID:29950665 NCBI chr 5:33,843,591...33,892,446
Ensembl chr 5:33,843,519...33,892,462 		JBrowse link
G Atp6v1e2 ATPase H+ transporting V1 subunit E2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP6V1E2 mRNA CTD PMID:29950665 NCBI chr 6:10,510,370...10,517,059
Ensembl chr 6:10,511,452...10,515,370 		JBrowse link
G Atp6v1g3 ATPase H+ transporting V1 subunit G3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP6V1G3 mRNA CTD PMID:29950665 NCBI chr13:55,265,794...55,288,651
Ensembl chr13:55,274,199...55,288,651 		JBrowse link
G Atp7a ATPase copper transporting alpha multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP7A mRNA CTD PMID:29950665 NCBI chr  X:77,076,085...77,193,644
Ensembl chr  X:77,076,106...77,193,644 		JBrowse link
G Atp8b1 ATPase phospholipid transporting 8B1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP8B1 mRNA CTD PMID:29950665 NCBI chr18:60,013,388...60,152,920
Ensembl chr18:60,013,382...60,095,354 		JBrowse link
G Atp8b2 ATPase phospholipid transporting 8B2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ATP8B2 mRNA CTD PMID:29950665 NCBI chr 2:189,285,961...189,306,947
Ensembl chr 2:189,285,953...189,307,108 		JBrowse link
G Avpr1a arginine vasopressin receptor 1A multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AVPR1A mRNA CTD PMID:29950665 NCBI chr 7:67,341,366...67,345,290
Ensembl chr 7:67,341,080...67,345,308 		JBrowse link
G Avpr1b arginine vasopressin receptor 1B multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of AVPR1B mRNA CTD PMID:29950665 NCBI chr13:48,367,307...48,378,831
Ensembl chr13:48,367,307...48,378,831 		JBrowse link
G Avpr2 arginine vasopressin receptor 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of AVPR2 mRNA CTD PMID:29950665 NCBI chr  X:156,889,006...156,892,707
Ensembl chr  X:156,889,410...156,891,213 		JBrowse link
G Axin2 axin 2 multiple interactions ISO [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of AXIN2 mRNA; [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of AXIN2 protein; pristimerin inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of AXIN2 mRNA]; pristimerin inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of AXIN2 protein] CTD PMID:31715269 NCBI chr10:97,212,483...97,238,824
Ensembl chr10:97,212,432...97,239,642 		JBrowse link
G B3gnt3 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of B3GNT3 mRNA CTD PMID:29950665 NCBI chr16:20,123,948...20,133,482
Ensembl chr16:20,123,948...20,133,322 		JBrowse link
G B3gnt7 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 decreases expression
multiple interactions		 ISO Dextran Sulfate results in decreased expression of B3GNT7 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of B3GNT7 protein]		 CTD PMID:32272095 NCBI chr 9:93,326,283...93,330,234
Ensembl chr 9:93,326,283...93,330,233 		JBrowse link
G B3gnt8 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of B3GNT8 mRNA CTD PMID:29950665 NCBI chr 1:82,419,264...82,422,852
Ensembl chr 1:82,419,947...82,422,846 		JBrowse link
G Baat bile acid CoA:amino acid N-acyltransferase multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BAAT mRNA CTD PMID:29950665 NCBI chr 5:64,768,397...64,777,368
Ensembl chr 5:64,768,401...64,777,368 		JBrowse link
G Banf1 BAF nuclear assembly factor 1 multiple interactions
decreases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of BANF1 protein] CTD PMID:32272095 NCBI chr 1:220,744,195...220,746,224
Ensembl chr 1:220,744,195...220,746,224 		JBrowse link
G Bank1 B-cell scaffold protein with ankyrin repeats 1 increases expression ISO Dextran Sulfate results in increased expression of BANK1 mRNA CTD PMID:23894361 NCBI chr 2:241,273,763...241,545,527
Ensembl chr 2:241,273,763...241,545,250 		JBrowse link
G Bax BCL2 associated X, apoptosis regulator multiple interactions ISO [RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in increased expression of BAX mRNA; [RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in increased expression of BAX protein CTD PMID:24146755 NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207 		JBrowse link
G Bche butyrylcholinesterase multiple interactions
decreases activity		 ISO [Chlorpyrifos co-treated with Dextran Sulfate] results in decreased activity of BCHE protein
Dextran Sulfate results in decreased activity of BCHE protein		 CTD PMID:31226429 PMID:31807802 NCBI chr 2:171,104,476...171,196,186
Ensembl chr 2:171,100,140...171,196,395 		JBrowse link
G Bcl2 BCL2, apoptosis regulator multiple interactions ISO [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein; Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein]; Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein]; Plant Extracts inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein] CTD PMID:25449198 NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374 		JBrowse link
G Bdkrb1 bradykinin receptor B1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of BDKRB1 mRNA CTD PMID:29950665 NCBI chr 6:129,437,423...129,441,553
Ensembl chr 6:129,438,158...129,440,574 		JBrowse link
G Bdkrb2 bradykinin receptor B2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of BDKRB2 mRNA CTD PMID:29950665 NCBI chr 6:129,399,468...129,429,676
Ensembl chr 6:129,399,468...129,429,676 		JBrowse link
G Becn1 beclin 1 multiple interactions
increases expression		 ISO 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[Dextran Sulfate co-treated with alpinetin] results in increased expression of BECN1 protein]; [Dextran Sulfate co-treated with 6-formylindolo(3,2-b)carbazole] results in increased expression of BECN1 protein; [Dextran Sulfate co-treated with alpinetin] results in increased expression of BECN1 protein; [Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of BECN1 protein; [HU 308 co-treated with Dextran Sulfate] affects the expression of BECN1 protein; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of BECN1 protein]; HU 308 promotes the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of BECN1 protein]; Leucine inhibits the reaction [[Dextran Sulfate co-treated with alpinetin] results in increased expression of BECN1 protein]; Nicotine promotes the reaction [Dextran Sulfate results in increased expression of BECN1 protein]
dorsomorphin inhibits the reaction [Nicotine promotes the reaction [Dextran Sulfate results in increased expression of BECN1 protein]]; Nicotine promotes the reaction [Dextran Sulfate results in increased expression of BECN1 protein]		 CTD PMID:27611972 PMID:31676321 PMID:31926917 NCBI chr10:89,209,944...89,225,297
Ensembl chr10:89,209,940...89,225,297 		JBrowse link
G Best1 bestrophin 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BEST1 mRNA CTD PMID:29950665 NCBI chr 1:226,033,146...226,049,893
Ensembl chr 1:226,030,875...226,049,929 		JBrowse link
G Bgn biglycan multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of BGN mRNA CTD PMID:29950665 NCBI chr  X:157,319,042...157,331,204
Ensembl chr  X:157,319,046...157,331,204 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 multiple interactions ISO [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein; Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein]; Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein]; Plant Extracts inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein] CTD PMID:25449198 NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413 		JBrowse link
G Bmp1 bone morphogenetic protein 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of BMP1 mRNA CTD PMID:29950665 NCBI chr15:52,166,401...52,210,786
Ensembl chr15:52,166,401...52,210,746 		JBrowse link
G Bmp10 bone morphogenetic protein 10 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of BMP10 mRNA CTD PMID:29950665 NCBI chr 4:119,224,906...119,230,534
Ensembl chr 4:119,225,040...119,230,728 		JBrowse link
G Bmp7 bone morphogenetic protein 7 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of BMP7 mRNA CTD PMID:29950665 NCBI chr 3:170,879,972...170,955,820
Ensembl chr 3:170,879,973...170,955,399 		JBrowse link
G Bmpr1b bone morphogenetic protein receptor type 1B multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of BMPR1B mRNA CTD PMID:29950665 NCBI chr 2:247,392,195...247,662,026
Ensembl chr 2:247,403,920...247,446,882 		JBrowse link
G Bmpr2 bone morphogenetic protein receptor type 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BMPR2 mRNA CTD PMID:29950665 NCBI chr 9:66,568,074...66,683,019
Ensembl chr 9:66,568,074...66,676,494 		JBrowse link
G Bst1 bone marrow stromal cell antigen 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of BST1 mRNA CTD PMID:29950665 NCBI chr14:71,798,218...71,814,540
Ensembl chr14:71,798,651...71,814,523 		JBrowse link
G Btf3l4 basic transcription factor 3-like 4 decreases expression
multiple interactions		 ISO Dextran Sulfate results in decreased expression of BTF3L4 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of BTF3L4 protein]		 CTD PMID:32272095 NCBI chr 5:128,432,049...128,450,530
Ensembl chr 5:128,432,433...128,446,725 		JBrowse link
G C1galt1 core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of C1GALT1 mRNA CTD PMID:29950665 NCBI chr 4:33,890,353...33,943,219
Ensembl chr 4:33,890,349...33,943,211 		JBrowse link
G C1galt1c1 C1GALT1-specific chaperone 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of C1GALT1C1 mRNA CTD PMID:29950665 NCBI chr  X:124,921,686...124,926,171
Ensembl chr  X:124,921,728...124,926,171 		JBrowse link
G C1qa complement C1q A chain multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of C1QA mRNA CTD PMID:29950665 NCBI chr 5:155,261,254...155,264,101
Ensembl chr 5:155,261,250...155,264,143 		JBrowse link
G C1qb complement C1q B chain multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of C1QB mRNA CTD PMID:29950665 NCBI chr 5:155,246,444...155,251,995
Ensembl chr 5:155,246,447...155,252,003 		JBrowse link
G C1s complement C1s multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of C1S2 mRNA CTD PMID:29950665 NCBI chr 4:157,143,592...157,155,592
Ensembl chr 4:157,143,592...157,155,609 		JBrowse link
G C3 complement C3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of C3 mRNA CTD PMID:29950665 NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167 		JBrowse link
G C3ar1 complement C3a receptor 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of C3AR1 mRNA CTD PMID:29950665 NCBI chr 4:155,681,767...155,691,240
Ensembl chr 4:155,684,029...155,690,869 		JBrowse link
G C4b complement C4B (Chido blood group) multiple interactions
increases expression		 ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of C4B mRNA; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of C4B protein] CTD PMID:29950665 PMID:32272095 NCBI chr20:4,302,344...4,316,752
Ensembl chr20:4,302,344...4,316,715 		JBrowse link
G C5ar1 complement C5a receptor 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of C5AR1 mRNA CTD PMID:29950665 NCBI chr 1:78,186,777...78,195,132
Ensembl chr 1:78,186,776...78,195,328 		JBrowse link
G Ca3 carbonic anhydrase 3 multiple interactions
increases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in increased expression of CA3 protein] CTD PMID:32272095 NCBI chr 2:88,126,519...88,136,063
Ensembl chr 2:88,126,667...88,135,410 		JBrowse link
G Ca4 carbonic anhydrase 4 multiple interactions
decreases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CA4 protein] CTD PMID:32272095 NCBI chr10:72,272,286...72,281,069
Ensembl chr10:72,272,248...72,281,067 		JBrowse link
G Cab39 calcium binding protein 39 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CAB39 mRNA CTD PMID:29950665 NCBI chr 9:92,834,327...92,895,778
Ensembl chr 9:92,834,357...92,895,778 		JBrowse link
G Cacna1f calcium voltage-gated channel subunit alpha1 F multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CACNA1F mRNA CTD PMID:29950665 NCBI chr  X:15,712,709...15,741,135
Ensembl chr  X:15,712,713...15,741,103 		JBrowse link
G Cacna1s calcium voltage-gated channel subunit alpha1 S multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CACNA1S mRNA CTD PMID:29950665 NCBI chr13:52,889,570...52,964,558
Ensembl chr13:52,889,737...52,964,155 		JBrowse link
G Calca calcitonin-related polypeptide alpha multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CALCA mRNA CTD PMID:29950665 NCBI chr 1:184,184,018...184,188,922
Ensembl chr 1:184,184,020...184,188,911 		JBrowse link
G Calcb calcitonin-related polypeptide, beta multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CALCB mRNA CTD PMID:29950665 NCBI chr 1:184,271,116...184,276,480
Ensembl chr 1:184,271,590...184,276,475 		JBrowse link
G Calm1 calmodulin 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CALM1 mRNA CTD PMID:29950665 NCBI chr 6:124,217,241...124,225,292
Ensembl chr 6:124,217,241...124,225,292 		JBrowse link
G Camk2g calcium/calmodulin-dependent protein kinase II gamma multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CAMK2G mRNA CTD PMID:29950665 NCBI chr15:3,936,721...3,995,740
Ensembl chr15:3,936,786...3,995,915 		JBrowse link
G Camk4 calcium/calmodulin-dependent protein kinase IV multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CAMK4 mRNA CTD PMID:29950665 NCBI chr18:25,746,878...25,975,962
Ensembl chr18:25,749,098...25,965,957 		JBrowse link
G Camkk1 calcium/calmodulin-dependent protein kinase kinase 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CAMKK1 mRNA CTD PMID:29950665 NCBI chr10:59,585,023...59,608,180
Ensembl chr10:59,585,072...59,608,165 		JBrowse link
G Capn13 calpain 13 multiple interactions
decreases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CAPN13 protein] CTD PMID:32272095 NCBI chr 6:24,579,590...24,676,536
Ensembl chr 6:24,579,622...24,676,524 		JBrowse link
G Car2 carbonic anhydrase 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CAR2 mRNA CTD PMID:29950665 NCBI chr 2:88,097,740...88,112,868
Ensembl chr 2:88,097,720...88,113,029 		JBrowse link
G Casp1 caspase 1 multiple interactions
increases expression		 ISO
EXP		 3-methyladenine affects the reaction [[HU 308 co-treated with Dextran Sulfate] affects the cleavage of CASP1 protein]; [Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein; [Dextran Sulfate co-treated with Zearalenone] results in increased expression of CASP1 mRNA; [Dextran Sulfate co-treated with Zearalenone] results in increased expression of CASP1 protein; [HU 308 co-treated with Dextran Sulfate] affects the cleavage of CASP1 protein; ATG5 protein affects the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]]; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]; dorsomorphin inhibits the reaction [HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]]; HU 308 inhibits the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]
MCC-950 inhibits the reaction [Dextran Sulfate results in increased expression of CASP1 protein]; MCC-950 promotes the reaction [tripterine inhibits the reaction [Dextran Sulfate results in increased expression of CASP1 protein]]; tripterine inhibits the reaction [Dextran Sulfate results in increased expression of CASP1 protein]
Dextran Sulfate results in increased expression of CASP1 mRNA; Dextran Sulfate results in increased expression of CASP1 protein		 CTD PMID:27611972 PMID:30270565 PMID:32470352 NCBI chr 8:2,605,743...2,614,637
Ensembl chr 8:2,604,962...2,614,631 		JBrowse link
G Casp3 caspase 3 increases cleavage
increases activity
multiple interactions		 ISO Dextran Sulfate results in increased cleavage of CASP3 protein
Dextran Sulfate results in increased activity of CASP3 protein
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [alpinetin inhibits the reaction [Dextran Sulfate results in increased cleavage of CASP3 protein]]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [Dextran Sulfate results in increased cleavage of CASP3 protein]; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CASP3 mRNA; alpinetin inhibits the reaction [Dextran Sulfate results in increased cleavage of CASP3 protein]; EIF2AK2 protein affects the reaction [Dextran Sulfate results in increased activity of CASP3 protein]; Leucine inhibits the reaction [alpinetin inhibits the reaction [Dextran Sulfate results in increased cleavage of CASP3 protein]]; Plant Extracts inhibits the reaction [Dextran Sulfate results in increased cleavage of CASP3 protein]		 CTD PMID:21989142 PMID:27920257 PMID:29950665 PMID:31676321 NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204 		JBrowse link
G Casp8 caspase 8 multiple interactions
decreases expression		 ISO 15,16-dihydrotanshinone I inhibits the reaction [Dextran Sulfate results in decreased expression of CASP8 protein] CTD PMID:29496522 NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106 		JBrowse link
G Cat catalase decreases activity
multiple interactions		 ISO Dextran Sulfate results in decreased activity of CAT protein
mangiferin inhibits the reaction [Dextran Sulfate results in decreased activity of CAT protein]		 CTD PMID:27125760 NCBI chr 3:93,379,872...93,412,058
Ensembl chr 3:93,379,874...93,412,058 		JBrowse link
G Cbr3 carbonyl reductase 3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CBR3 mRNA CTD PMID:29950665 NCBI chr11:33,909,417...33,917,674
Ensembl chr11:33,909,439...33,917,674 		JBrowse link
G Ccdc158 coiled-coil domain containing 158 decreases expression
multiple interactions		 ISO Dextran Sulfate results in decreased expression of CCDC158 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CCDC158 protein]		 CTD PMID:32272095 NCBI chr14:16,917,138...16,976,240
Ensembl chr14:16,924,960...16,974,514 		JBrowse link
G Cckbr cholecystokinin B receptor multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CCKBR mRNA CTD PMID:29950665 NCBI chr 1:170,262,218...170,272,298
Ensembl chr 1:170,262,156...170,272,298 		JBrowse link
G Ccl11 C-C motif chemokine ligand 11 increases secretion
multiple interactions		 ISO Dextran Sulfate results in increased secretion of CCL11 protein
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCL11 mRNA; Tetrachlorodibenzodioxin inhibits the reaction [Dextran Sulfate results in increased secretion of CCL11 protein]		 CTD PMID:21858153 PMID:29950665 NCBI chr10:69,434,965...69,439,566
Ensembl chr10:69,434,941...69,439,575 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions
increases expression
increases secretion		 ISO [RASSF1 gene mutant form results in increased susceptibility to Dextran Sulfate] which results in increased secretion of CCL2 protein; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCL2 mRNA; Tetrachlorodibenzodioxin inhibits the reaction [Dextran Sulfate results in increased secretion of CCL2 protein]
Dextran Sulfate results in increased expression of CCL2 mRNA		 CTD PMID:19645018 PMID:20079348 PMID:21858153 PMID:24146755 PMID:29950665 PMID:31807802 NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870 		JBrowse link
G Ccl21 C-C motif chemokine ligand 21 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCL21A mRNA CTD PMID:29950665 NCBI chr 5:58,197,678...58,198,782
Ensembl chr 5:58,197,680...58,198,782 		JBrowse link
G Ccl24 C-C motif chemokine ligand 24 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCL24 mRNA CTD PMID:29950665 NCBI chr12:24,131,529...24,152,626
Ensembl chr12:24,148,567...24,152,625 		JBrowse link
G Ccl25 C-C motif chemokine ligand 25 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CCL25 mRNA CTD PMID:29950665 NCBI chr12:2,429,492...2,438,928
Ensembl chr12:2,429,509...2,438,817 		JBrowse link
G Ccl28 C-C motif chemokine ligand 28 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CCL28 mRNA CTD PMID:29950665 NCBI chr 2:52,379,341...52,403,979
Ensembl chr 2:52,379,341...52,404,246 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression
multiple interactions		 ISO
EXP		 Dextran Sulfate results in increased expression of CCL3 mRNA
Dextran Sulfate results in increased expression of CCL3 protein
Hesperidin inhibits the reaction [Dextran Sulfate results in increased expression of CCL3 protein]		 CTD PMID:19645018 PMID:30811821 NCBI chr10:70,869,516...70,871,066
Ensembl chr10:70,869,513...70,871,066 		JBrowse link
G Ccl4 C-C motif chemokine ligand 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCL4 mRNA CTD PMID:29950665 NCBI chr10:70,870,926...70,886,357
Ensembl chr10:70,884,531...70,886,355 		JBrowse link
G Ccl6 C-C motif chemokine ligand 6 decreases expression ISO Dextran Sulfate results in decreased expression of CCL6 mRNA CTD PMID:19645018 NCBI chr10:70,798,118...70,802,750
Ensembl chr10:70,797,124...70,802,782 		JBrowse link
G Ccl7 C-C motif chemokine ligand 7 increases expression
multiple interactions		 ISO Dextran Sulfate results in increased expression of CCL7 mRNA
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCL7 mRNA		 CTD PMID:19645018 PMID:29950665 NCBI chr10:69,423,083...69,424,933
Ensembl chr10:69,423,086...69,424,979 		JBrowse link
G Ccnd1 cyclin D1 multiple interactions ISO [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of CCND1 mRNA; [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of CCND1 protein; pristimerin inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of CCND1 mRNA]; pristimerin inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of CCND1 protein] CTD PMID:31715269 NCBI chr 1:218,090,750...218,100,447
Ensembl chr 1:218,090,750...218,100,325 		JBrowse link
G Ccr2 C-C motif chemokine receptor 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCR2 mRNA CTD PMID:29950665
G Ccr4 C-C motif chemokine receptor 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCR4 mRNA CTD PMID:29950665 NCBI chr 8:122,530,152...122,535,959
Ensembl chr 8:122,530,624...122,532,070 		JBrowse link
G Ccr5 C-C motif chemokine receptor 5 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCR5 mRNA CTD PMID:29950665 NCBI chr 8:133,192,398...133,215,599
Ensembl chr 8:133,197,032...133,215,614 		JBrowse link
G Ccr8 C-C motif chemokine receptor 8 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCR8 mRNA CTD PMID:29950665 NCBI chr 8:128,779,552...128,782,531
Ensembl chr 8:128,781,395...128,782,456 		JBrowse link
G Ccrl2 C-C motif chemokine receptor like 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCRL2 mRNA CTD PMID:29950665 NCBI chr 8:119,324,298...119,326,954
Ensembl chr 8:119,324,613...119,326,938 		JBrowse link
G Cd14 CD14 molecule affects response to substance
multiple interactions		 ISO Dextran Sulfate affects the susceptibility to CD14 protein
[Dextran Sulfate affects the susceptibility to CD14 protein] which affects the expression of IFNG mRNA; CD14 protein inhibits the reaction [Dextran Sulfate results in increased expression of TNF mRNA]		 CTD PMID:28411859 NCBI chr18:29,560,341...29,562,290
Ensembl chr18:29,560,365...29,562,153 		JBrowse link
G Cd177 CD177 molecule increases expression ISO Dextran Sulfate results in increased expression of CD177 mRNA CTD PMID:23894361 NCBI chr 1:82,964,683...82,987,306
Ensembl chr 1:82,964,683...82,987,253 		JBrowse link
G Cd180 CD180 molecule increases expression
multiple interactions		 ISO Dextran Sulfate results in increased expression of CD180 mRNA
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CD180 mRNA		 CTD PMID:23894361 PMID:29950665 NCBI chr 2:32,820,275...32,833,223
Ensembl chr 2:32,820,322...32,833,125 		JBrowse link
G Cd19 CD19 molecule increases expression ISO Dextran Sulfate results in increased expression of CD19 mRNA CTD PMID:23894361 NCBI chr 1:197,815,422...197,822,123
Ensembl chr 1:197,815,413...197,821,936 		JBrowse link
G Cd200 Cd200 molecule multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CD200 mRNA CTD PMID:29950665 NCBI chr11:60,371,617...60,398,450
Ensembl chr11:60,371,684...60,403,196 		JBrowse link
G Cd247 Cd247 molecule multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CD247 mRNA CTD PMID:29950665 NCBI chr13:83,996,045...84,071,408
Ensembl chr13:83,996,080...84,071,400 		JBrowse link
G Cd274 CD274 molecule multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CD274 mRNA CTD PMID:29950665 NCBI chr 1:247,519,890...247,539,659
Ensembl chr 1:247,519,939...247,537,943 		JBrowse link
G Cd28 Cd28 molecule multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CD28 mRNA CTD PMID:29950665 NCBI chr 9:67,546,408...67,573,858
Ensembl chr 9:67,546,408...67,571,871 		JBrowse link
G Cd4 Cd4 molecule multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CD4 mRNA CTD PMID:29950665 NCBI chr 4:157,381,862...157,408,357
Ensembl chr 4:157,383,052...157,408,176 		JBrowse link
G Cd44 CD44 molecule (Indian blood group) multiple interactions ISO [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of CD44 mRNA CTD PMID:26271895 NCBI chr 3:92,695,083...92,783,820
Ensembl chr 3:92,696,313...92,783,658 		JBrowse link
G Cd52 CD52 molecule increases expression ISO Dextran Sulfate results in increased expression of CD52 mRNA CTD PMID:23894361 NCBI chr 5:152,322,910...152,324,469
Ensembl chr 5:152,322,916...152,324,469 		JBrowse link
G Cd53 Cd53 molecule increases expression ISO Dextran Sulfate results in increased expression of CD53 mRNA CTD PMID:23894361 NCBI chr 2:209,489,279...209,537,098
Ensembl chr 2:209,489,279...209,537,087 		JBrowse link
G Cd55 CD55 molecule (Cromer blood group) multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CD55 mRNA CTD PMID:29950665 NCBI chr13:47,125,156...47,153,557
Ensembl chr13:47,126,741...47,154,292 		JBrowse link
G Cd72 Cd72 molecule increases expression ISO Dextran Sulfate results in increased expression of CD72 mRNA CTD PMID:23894361 NCBI chr 5:58,943,021...58,950,373
Ensembl chr 5:58,943,027...58,950,373 		JBrowse link
G Cd74 CD74 molecule increases expression ISO Dextran Sulfate results in increased expression of CD74 mRNA CTD PMID:23894361 NCBI chr18:56,071,420...56,080,851
Ensembl chr18:56,071,478...56,080,849 		JBrowse link
G Cd79a CD79a molecule increases expression ISO Dextran Sulfate results in increased expression of CD79A mRNA CTD PMID:23894361 NCBI chr 1:81,763,609...81,768,039
Ensembl chr 1:81,763,614...81,767,980 		JBrowse link
G Cd79b CD79b molecule increases expression ISO Dextran Sulfate results in increased expression of CD79B mRNA CTD PMID:23894361 NCBI chr10:94,497,445...94,500,591
Ensembl chr10:94,497,448...94,500,591 		JBrowse link
G Cd86 CD86 molecule multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CD86 mRNA CTD PMID:29950665 NCBI chr11:67,060,305...67,117,990
Ensembl chr11:67,082,193...67,118,795 		JBrowse link
G Cda cytidine deaminase multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CDA mRNA CTD PMID:29950665 NCBI chr 5:156,703,579...156,734,541
Ensembl chr 5:156,703,579...156,734,541 		JBrowse link
G Cdh1 cadherin 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CDH1 mRNA CTD PMID:29950665 NCBI chr19:38,768,467...38,838,395
Ensembl chr19:38,768,467...38,838,395 		JBrowse link
G Cdh5 cadherin 5 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CDH5 mRNA CTD PMID:29950665 NCBI chr19:1,025,122...1,074,333
Ensembl chr19:1,023,683...1,074,365 		JBrowse link
G Cdhr2 cadherin-related family member 2 decreases expression
multiple interactions		 ISO Dextran Sulfate results in decreased expression of CDHR2 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CDHR2 protein]		 CTD PMID:32272095 NCBI chr17:10,415,044...10,450,589
Ensembl chr17:10,415,123...10,439,691 		JBrowse link
G Cdkn1c cyclin-dependent kinase inhibitor 1C multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CDKN1C mRNA CTD PMID:29950665 NCBI chr 1:216,661,067...216,663,791
Ensembl chr 1:216,661,080...216,663,721 		JBrowse link
G Cdx2 caudal type homeo box 2 increases expression
multiple interactions		 ISO Dextran Sulfate results in increased expression of CDX2 protein
6-formylindolo(3,2-b)carbazole inhibits the reaction [Dextran Sulfate results in increased expression of CDX2 protein]		 CTD PMID:29680209 NCBI chr12:9,464,026...9,470,565
Ensembl chr12:9,464,026...9,470,565 		JBrowse link
G Cel carboxyl ester lipase multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CEL mRNA CTD PMID:29950665 NCBI chr 3:7,134,021...7,141,522
Ensembl chr 3:7,134,021...7,141,522 		JBrowse link
G Ces1d carboxylesterase 1D multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CES1D mRNA CTD PMID:29950665 NCBI chr19:15,195,514...15,239,827
Ensembl chr19:15,033,108...15,239,821 		JBrowse link
G Ces2c carboxylesterase 2C multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CES2C mRNA CTD PMID:29950665 NCBI chr 1:282,640,752...282,648,319
Ensembl chr 1:282,638,017...282,702,424 		JBrowse link
G Cfh complement factor H multiple interactions
increases expression		 ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CFH mRNA; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of CFH protein] CTD PMID:29950665 PMID:32272095 NCBI chr13:56,979,155...57,080,540
Ensembl chr13:56,978,607...57,080,622 		JBrowse link
G Cflar CASP8 and FADD-like apoptosis regulator multiple interactions ISO [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein; Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein]; Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein]; Plant Extracts inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFLAR protein] CTD PMID:25449198 NCBI chr 9:65,534,608...65,586,395
Ensembl chr 9:65,534,704...65,587,251 		JBrowse link
G Cftr CF transmembrane conductance regulator multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CFTR mRNA CTD PMID:29950665 NCBI chr 4:42,693,263...42,860,679
Ensembl chr 4:42,692,836...42,860,676 		JBrowse link
G Cherp calcium homeostasis endoplasmic reticulum protein multiple interactions
decreases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CHERP protein] CTD PMID:32272095 NCBI chr16:19,068,783...19,081,837
Ensembl chr16:19,068,783...19,081,837 		JBrowse link
G Chmp2a charged multivesicular body protein 2A decreases expression
multiple interactions		 ISO Dextran Sulfate results in decreased expression of CHMP2A protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CHMP2A protein]		 CTD PMID:32272095 NCBI chr 1:65,540,808...65,543,708
Ensembl chr 1:65,541,322...65,543,707 		JBrowse link
G Chn2 chimerin 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CHN2 mRNA CTD PMID:29950665 NCBI chr 4:84,423,708...84,452,989
Ensembl chr 4:84,194,347...84,454,500 		JBrowse link
G Chrdl2 chordin-like 2 increases expression ISO Dextran Sulfate results in increased expression of CHRDL2 mRNA CTD PMID:23894361 NCBI chr 1:165,008,997...165,036,431
Ensembl chr 1:165,008,912...165,036,435 		JBrowse link
G Chrm4 cholinergic receptor, muscarinic 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CHRM4 mRNA CTD PMID:29950665 NCBI chr 3:80,833,272...80,841,165
Ensembl chr 3:80,833,272...80,841,006 		JBrowse link
G Chrna2 cholinergic receptor nicotinic alpha 2 subunit multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CHRNA2 mRNA CTD PMID:29950665 NCBI chr15:42,808,897...42,825,179
Ensembl chr15:42,808,897...42,825,179 		JBrowse link
G Chrna7 cholinergic receptor nicotinic alpha 7 subunit multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CHRNA7 mRNA CTD PMID:29950665 NCBI chr 1:123,897,341...124,039,263
Ensembl chr 1:123,899,657...124,039,196 		JBrowse link
G Chrnb3 cholinergic receptor nicotinic beta 3 subunit multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CHRNB3 mRNA CTD PMID:29950665 NCBI chr16:68,876,442...68,913,628
Ensembl chr16:68,875,709...68,913,628 		JBrowse link
G Chrne cholinergic receptor nicotinic epsilon subunit multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CHRNE mRNA CTD PMID:29950665 NCBI chr10:57,238,960...57,246,750
Ensembl chr10:57,238,946...57,243,435 		JBrowse link
G Chst11 carbohydrate sulfotransferase 11 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CHST11 mRNA CTD PMID:29950665 NCBI chr 7:26,641,856...26,890,503
Ensembl chr 7:26,645,422...26,859,716 		JBrowse link
G Chuk component of inhibitor of nuclear factor kappa B kinase complex increases expression
multiple interactions		 ISO Dextran Sulfate results in increased expression of CHUK protein modified form
notoginsenoside R1 inhibits the reaction [Dextran Sulfate results in increased expression of CHUK protein modified form]		 CTD PMID:25472953 NCBI chr 1:263,848,829...263,884,354
Ensembl chr 1:263,848,884...263,885,169 		JBrowse link
G Clca1 chloride channel accessory 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CLCA1 mRNA CTD PMID:29950665 NCBI chr 2:250,897,980...250,923,711
Ensembl chr 2:250,897,969...250,923,744 		JBrowse link
G Clca4 chloride channel accessory 4 increases expression ISO Dextran Sulfate results in increased expression of CLCA4 mRNA CTD PMID:23894361 NCBI chr 2:250,842,939...250,864,060
Ensembl chr 2:250,843,165...250,862,419 		JBrowse link
G Clcn2 chloride voltage-gated channel 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CLCN2 mRNA CTD PMID:29950665 NCBI chr11:82,862,664...82,876,165
Ensembl chr11:83,883,879...83,897,394 		JBrowse link
G Clcn3 chloride voltage-gated channel 3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CLCN3 mRNA CTD PMID:29950665 NCBI chr16:32,448,821...32,520,649
Ensembl chr16:32,449,116...32,519,148 		JBrowse link
G Cldn1 claudin 1 multiple interactions
decreases expression		 ISO [SB 203580 co-treated with Dextran Sulfate] results in decreased expression of CLDN1 protein; [Win 55212-2 co-treated with Dextran Sulfate] results in decreased expression of CLDN1 protein
Dextran Sulfate results in decreased expression of CLDN1 protein		 CTD PMID:27920472 NCBI chr11:77,815,216...77,830,373
Ensembl chr11:77,815,181...77,830,416 		JBrowse link
G Cldn11 claudin 11 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CLDN11 mRNA CTD PMID:29950665 NCBI chr 2:115,823,541...115,836,846
Ensembl chr 2:115,823,538...115,836,846 		JBrowse link
G Cldn2 claudin 2 multiple interactions
increases expression		 ISO 6-formylindolo(3,2-b)carbazole inhibits the reaction [Dextran Sulfate results in increased expression of CLDN2 mRNA]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [Dextran Sulfate results in increased expression of CLDN2 protein]; [Benzo(a)pyrene co-treated with Dextran Sulfate] results in decreased expression of CLDN2 mRNA
Dextran Sulfate results in increased expression of CLDN2 mRNA; Dextran Sulfate results in increased expression of CLDN2 protein		 CTD PMID:26271895 PMID:29680209 NCBI chr  X:111,122,552...111,133,188
Ensembl chr  X:111,122,552...111,137,769 		JBrowse link
G Cma1 chymase 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CMA1 mRNA CTD PMID:29950665 NCBI chr15:34,601,037...34,603,819
Ensembl chr15:34,601,037...34,603,819 		JBrowse link
G Cmas cytidine monophosphate N-acetylneuraminic acid synthetase multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CMAS mRNA CTD PMID:29950665 NCBI chr 4:176,994,129...177,012,445
Ensembl chr 4:176,994,129...177,012,444 		JBrowse link
G Cnga4 cyclic nucleotide gated channel subunit alpha 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CNGA4 mRNA CTD PMID:29950665 NCBI chr 1:170,238,959...170,246,858
Ensembl chr 1:170,242,846...170,246,858 		JBrowse link
G Cnr1 cannabinoid receptor 1 decreases response to substance
increases expression
multiple interactions		 ISO CNR1 results in decreased susceptibility to Dextran Sulfate
Dextran Sulfate results in increased expression of CNR1 protein
SB 203580 inhibits the reaction [Dextran Sulfate results in increased expression of CNR1 protein]; Serotonin inhibits the reaction [Dextran Sulfate results in increased expression of CNR1 protein]		 CTD PMID:15085199 PMID:27920472 PMID:30611738 NCBI chr 5:49,307,584...49,333,064
Ensembl chr 5:49,311,030...49,333,056 		JBrowse link
G Cnr2 cannabinoid receptor 2 multiple interactions
affects response to substance
increases expression		 ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CNR2 mRNA; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in decreased expression of SQSTM1 protein]; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased cleavage of CASP1 protein]; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of and results in increased secretion of IL1B protein]; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of BECN1 protein]; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of IL1B mRNA]; CNR2 protein affects the reaction [[Dextran Sulfate co-treated with Lipopolysaccharides] results in increased expression of NLRP3 protein]; CNR2 protein affects the reaction [Dextran Sulfate results in decreased phosphorylation of MTOR protein]; CNR2 protein affects the reaction [Dextran Sulfate results in decreased phosphorylation of RPS6KB1 protein]; CNR2 protein affects the susceptibility to [Azoxymethane co-treated with Dextran Sulfate]; SB 203580 inhibits the reaction [Dextran Sulfate results in increased expression of CNR2 protein]
CNR2 protein affects the susceptibility to Dextran Sulfate		 CTD PMID:27611972 PMID:27920472 PMID:29950665 PMID:32942172 NCBI chr 5:154,242,010...154,268,126
Ensembl chr 5:154,260,062...154,268,126 		JBrowse link
G Cntfr ciliary neurotrophic factor receptor multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CNTFR mRNA CTD PMID:29950665 NCBI chr 5:58,041,114...58,078,687
Ensembl chr 5:58,041,146...58,078,545 		JBrowse link
G Cntn1 contactin 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CNTN1 mRNA CTD PMID:29950665 NCBI chr 7:133,290,606...133,588,314
Ensembl chr 7:133,400,485...133,586,677 		JBrowse link
G Cog1 component of oligomeric golgi complex 1 multiple interactions
decreases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of COG1 protein] CTD PMID:32272095 NCBI chr10:102,167,594...102,180,569
Ensembl chr10:102,167,771...102,180,569 		JBrowse link
G Col11a1 collagen type XI alpha 1 chain multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL11A1 mRNA CTD PMID:29950665 NCBI chr 2:216,863,423...217,056,523
Ensembl chr 2:216,863,428...217,056,523 		JBrowse link
G Col14a1 collagen type XIV alpha 1 chain multiple interactions
increases expression		 ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL14A1 mRNA; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of COL14A1 protein] CTD PMID:29950665 PMID:32272095 NCBI chr 7:95,054,877...95,274,073
Ensembl chr 7:95,074,236...95,273,298 		JBrowse link
G Col18a1 collagen type XVIII alpha 1 chain multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL18A1 mRNA CTD PMID:29950665 NCBI chr20:12,225,202...12,332,858
Ensembl chr20:12,225,202...12,332,858 		JBrowse link
G Col1a1 collagen type I alpha 1 chain multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL1A1 mRNA CTD PMID:29950665 NCBI chr10:82,745,801...82,762,790
Ensembl chr10:82,745,801...82,762,789 		JBrowse link
G Col23a1 collagen type XXIII alpha 1 chain multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL23A1 mRNA CTD PMID:29950665 NCBI chr10:34,846,618...34,934,991
Ensembl chr10:34,903,343...34,933,539 		JBrowse link
G Col28a1 collagen type XXVIII alpha 1 chain multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL28A1 mRNA CTD PMID:29950665 NCBI chr 4:34,048,074...34,198,558
Ensembl chr 4:34,048,533...34,194,764 		JBrowse link
G Col4a1 collagen type IV alpha 1 chain multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL4A1 mRNA CTD PMID:29950665 NCBI chr16:83,522,162...83,632,153
Ensembl chr16:83,522,162...83,632,153 		JBrowse link
G Col4a2 collagen type IV alpha 2 chain multiple interactions
decreases expression		 ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL4A2 mRNA; Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of COL4A2 protein] CTD PMID:29950665 PMID:32272095 NCBI chr16:83,386,388...83,522,169
Ensembl chr16:83,387,364...83,438,561 		JBrowse link
G Col5a1 collagen type V alpha 1 chain multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL5A1 mRNA CTD PMID:29950665 NCBI chr 3:6,430,180...6,581,010
Ensembl chr 3:6,430,201...6,578,882 		JBrowse link
G Col5a2 collagen type V alpha 2 chain multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL5A2 mRNA CTD PMID:29950665 NCBI chr 9:52,091,088...52,238,735
Ensembl chr 9:52,092,511...52,238,564 		JBrowse link
G Col6a1 collagen type VI alpha 1 chain multiple interactions
decreases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of COL6A1 protein] CTD PMID:32272095 NCBI chr20:12,657,913...12,676,370
Ensembl chr20:12,658,065...12,675,561 		JBrowse link
G Col6a2 collagen type VI alpha 2 chain decreases expression
multiple interactions		 ISO Dextran Sulfate results in decreased expression of COL6A2 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of COL6A2 protein]		 CTD PMID:32272095 NCBI chr20:12,773,472...12,801,179
Ensembl chr20:12,773,427...12,801,180 		JBrowse link
G Col8a1 collagen type VIII alpha 1 chain multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of COL8A1 mRNA CTD PMID:29950665 NCBI chr11:44,877,690...45,006,203
Ensembl chr11:44,877,859...45,007,891 		JBrowse link
G Cp ceruloplasmin multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CP mRNA CTD PMID:29950665 NCBI chr 2:104,744,249...104,803,034
Ensembl chr 2:104,744,461...104,799,853 		JBrowse link
G Cpa1 carboxypeptidase A1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CPA1 mRNA CTD PMID:29950665 NCBI chr 4:57,952,982...57,959,109
Ensembl chr 4:57,952,982...57,959,109 		JBrowse link
G Cpb2 carboxypeptidase B2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CPB2 mRNA CTD PMID:29950665 NCBI chr15:57,290,849...57,339,762
Ensembl chr15:57,290,849...57,339,760 		JBrowse link
G Cr2 complement C3d receptor 2 increases expression ISO Dextran Sulfate results in increased expression of CR2 mRNA CTD PMID:23894361 NCBI chr13:113,890,274...113,927,824
Ensembl chr13:113,890,272...113,927,877 		JBrowse link
G Crhr1 corticotropin releasing hormone receptor 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CRHR1 mRNA CTD PMID:29950665 NCBI chr10:92,191,473...92,233,662
Ensembl chr10:92,191,718...92,232,645 		JBrowse link
G Crhr2 corticotropin releasing hormone receptor 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CRHR2 mRNA CTD PMID:29950665 NCBI chr 4:85,286,371...85,329,374
Ensembl chr 4:85,286,372...85,329,362 		JBrowse link
G Crtap cartilage associated protein multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CRTAP mRNA CTD PMID:29950665 NCBI chr 8:122,382,613...122,402,209 JBrowse link
G Csf1 colony stimulating factor 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CSF1 mRNA CTD PMID:29950665 NCBI chr 2:210,522,370...210,550,546
Ensembl chr 2:210,522,375...210,550,560 		JBrowse link
G Csf2 colony stimulating factor 2 increases expression
multiple interactions		 ISO Dextran Sulfate results in increased expression of CSF2 mRNA; Dextran Sulfate results in increased expression of CSF2 protein
[Ampicillin co-treated with Vancomycin co-treated with Neomycin co-treated with Metronidazole] inhibits the reaction [Dextran Sulfate results in increased expression of CSF2 protein]; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CSF2 mRNA; Polymyxin B inhibits the reaction [Dextran Sulfate results in increased expression of CSF2 protein]; Rutin inhibits the reaction [Dextran Sulfate results in increased expression of CSF2 mRNA]; TLR4 protein affects the reaction [Dextran Sulfate results in increased expression of CSF2 protein]		 CTD PMID:15652231 PMID:29950665 PMID:31442584 NCBI chr10:39,602,089...39,604,070
Ensembl chr10:39,602,089...39,604,070 		JBrowse link
G Csf2rb colony stimulating factor 2 receptor subunit beta multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CSF2RB2 mRNA CTD PMID:29950665 NCBI chr 7:119,554,383...119,568,248
Ensembl chr 7:119,554,354...119,568,776 		JBrowse link
G Csf3r colony stimulating factor 3 receptor multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CSF3R mRNA CTD PMID:29950665 NCBI chr 5:144,031,353...144,051,966
Ensembl chr 5:144,031,402...144,051,600 		JBrowse link
G Ctnnb1 catenin beta 1 increases expression
multiple interactions		 ISO Dextran Sulfate results in increased expression of CTNNB1 protein
[2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with Dextran Sulfate] results in increased expression of CTNNB1 protein; [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with Dextran Sulfate] results in increased mutagenesis of CTNNB1 gene; [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of CTNNB1 protein; CTNNB1 gene mutant form results in increased susceptibility to [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with Dextran Sulfate]; pristimerin inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of CTNNB1 protein]		 CTD PMID:15459021 PMID:16049979 PMID:27664423 PMID:31715269 NCBI chr 8:129,601,511...129,628,378
Ensembl chr 8:129,617,812...129,627,372 		JBrowse link
G Ctps1 CTP synthase 1 decreases expression
multiple interactions		 ISO Dextran Sulfate results in decreased expression of CTPS1 protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CTPS1 protein]		 CTD PMID:32272095 NCBI chr 5:139,475,934...139,505,065
Ensembl chr 5:139,475,934...139,505,065 		JBrowse link
G Ctsd cathepsin D multiple interactions
increases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in increased expression of CTSD protein] CTD PMID:32272095 NCBI chr 1:215,541,570...215,553,446
Ensembl chr 1:215,541,542...215,553,451 		JBrowse link
G Ctsk cathepsin K multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CTSK mRNA CTD PMID:29950665 NCBI chr 2:196,655,469...196,666,447
Ensembl chr 2:196,655,469...196,666,446 		JBrowse link
G Ctsl cathepsin L multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CTSL mRNA CTD PMID:29950665 NCBI chr17:1,873,105...1,879,266
Ensembl chr17:1,872,848...1,879,279 		JBrowse link
G Ctss cathepsin S multiple interactions
decreases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of CTSS protein] CTD PMID:32272095 NCBI chr 2:197,655,780...197,679,768
Ensembl chr 2:197,655,786...197,679,458 		JBrowse link
G Cubn cubilin multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CUBN mRNA CTD PMID:29950665 NCBI chr17:80,584,921...80,807,181
Ensembl chr17:80,584,878...80,807,243 		JBrowse link
G Cx3cr1 C-X3-C motif chemokine receptor 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CX3CR1 mRNA CTD PMID:29950665 NCBI chr 8:128,740,756...128,754,514
Ensembl chr 8:128,740,756...128,754,514 		JBrowse link
G Cxadr CXADR, Ig-like cell adhesion molecule multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CXADR mRNA CTD PMID:29950665 NCBI chr11:16,826,269...16,873,564
Ensembl chr11:16,826,399...16,873,562 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 multiple interactions ISO [Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CXCL10 mRNA; isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CXCL10 mRNA] CTD PMID:25026504 NCBI chr14:17,210,733...17,212,930
Ensembl chr14:17,210,733...17,212,930 		JBrowse link
G Cxcl13 C-X-C motif chemokine ligand 13 increases expression ISO Dextran Sulfate results in increased expression of CXCL13 mRNA CTD PMID:23894361 NCBI chr14:15,253,146...15,258,221
Ensembl chr14:15,253,125...15,258,207 		JBrowse link
G Cxcl14 C-X-C motif chemokine ligand 14 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CXCL14 mRNA CTD PMID:29950665 NCBI chr17:9,109,731...9,117,754
Ensembl chr17:9,109,731...9,117,750 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 multiple interactions
increases expression		 ISO 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Dextran Sulfate results in increased expression of CXCL2 protein]; resolvin D1 inhibits the reaction [Dextran Sulfate results in increased expression of CXCL2 protein]; resolvin D2 inhibits the reaction [Dextran Sulfate results in increased expression of CXCL2 protein] CTD PMID:21724996 NCBI chr14:18,731,346...18,733,391
Ensembl chr14:18,731,378...18,733,391 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 multiple interactions
increases secretion
increases expression		 ISO 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid inhibits the reaction [Dextran Sulfate results in increased expression of CXCL1 protein]; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CXCL1 mRNA; resolvin D1 inhibits the reaction [Dextran Sulfate results in increased expression of CXCL1 protein]; resolvin D2 inhibits the reaction [Dextran Sulfate results in increased expression of CXCL1 protein]; Tetrachlorodibenzodioxin inhibits the reaction [Dextran Sulfate results in increased secretion of CXCL1 protein]
Dextran Sulfate results in increased expression of CXCL1 mRNA; Dextran Sulfate results in increased expression of CXCL1 protein		 CTD PMID:19645018 PMID:20079348 PMID:21724996 PMID:21858153 PMID:29950665 PMID:31807802 NCBI chr14:18,820,168...18,839,659
Ensembl chr14:18,820,168...18,839,595 		JBrowse link
G Cxcl6 C-X-C motif chemokine ligand 6 increases expression
multiple interactions		 ISO Dextran Sulfate results in increased expression of CXCL5 mRNA
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CXCL5 mRNA		 CTD PMID:19645018 PMID:29950665 NCBI chr14:18,860,201...18,920,839
Ensembl chr14:18,860,264...18,862,407 		JBrowse link
G Cxcl9 C-X-C motif chemokine ligand 9 increases expression ISO Dextran Sulfate results in increased expression of CXCL9 mRNA CTD PMID:23894361 NCBI chr14:17,228,832...17,233,743
Ensembl chr14:17,228,856...17,234,712 		JBrowse link
G Cxcr2 C-X-C motif chemokine receptor 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CXCR2 mRNA CTD PMID:29950665 NCBI chr 9:81,427,275...81,435,065
Ensembl chr 9:81,427,730...81,434,102 		JBrowse link
G Cyba cytochrome b-245 alpha chain increases expression ISO Dextran Sulfate results in increased expression of CYBA protein CTD PMID:20637373 NCBI chr19:55,249,634...55,257,824
Ensembl chr19:55,249,616...55,257,876 		JBrowse link
G Cybb cytochrome b-245 beta chain increases expression ISO Dextran Sulfate results in increased expression of CYBB mRNA; Dextran Sulfate results in increased expression of CYBB protein CTD PMID:20637373 PMID:23894361 NCBI chr  X:14,578,330...14,610,049
Ensembl chr  X:14,578,264...14,612,547 		JBrowse link
G Cyfip1 cytoplasmic FMR1 interacting protein 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYFIP1 mRNA CTD PMID:29950665 NCBI chr 1:114,258,773...114,347,138
Ensembl chr 1:114,258,719...114,347,137 		JBrowse link
G Cyfip2 cytoplasmic FMR1 interacting protein 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYFIP2 mRNA CTD PMID:29950665 NCBI chr10:31,278,746...31,419,235
Ensembl chr10:31,278,746...31,419,235 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions
decreases expression		 ISO 6-formylindolo(3,2-b)carbazole inhibits the reaction [Dextran Sulfate results in decreased expression of CYP1A1 mRNA]; 6-formylindolo(3,2-b)carbazole inhibits the reaction [Dextran Sulfate results in decreased expression of CYP1A1 protein]
Dextran Sulfate results in decreased expression of CYP1A1 mRNA; Dextran Sulfate results in decreased expression of CYP1A1 protein		 CTD PMID:29680209 NCBI chr 8:62,472,087...62,478,122
Ensembl chr 8:62,472,095...62,478,147 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 multiple interactions
decreases activity		 EXP [Dextran Sulfate results in decreased activity of CYP1A2 protein] which results in decreased chemical synthesis of Acetaminophen CTD PMID:28438436 NCBI chr 8:62,451,360...62,458,244
Ensembl chr 8:62,451,329...62,458,301 		JBrowse link
G Cyp21a1 cytochrome P450, family 21, subfamily a, polypeptide 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP21A1 mRNA CTD PMID:29950665 NCBI chr20:4,486,213...4,489,358
Ensembl chr20:4,486,219...4,489,550 		JBrowse link
G Cyp27b1 cytochrome P450, family 27, subfamily b, polypeptide 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP27B1 mRNA CTD PMID:29950665 NCBI chr 7:70,333,150...70,340,006
Ensembl chr 7:70,335,061...70,340,005 		JBrowse link
G Cyp2b1 cytochrome P450, family 2, subfamily b, polypeptide 1 decreases activity
multiple interactions		 EXP
ISO		 Dextran Sulfate results in decreased activity of CYP2B1 protein
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYP2B10 mRNA
[Dextran Sulfate results in decreased activity of CYP2B1 protein] which results in decreased chemical synthesis of hydroxybupropion		 CTD PMID:28438436 PMID:29950665 NCBI chr 7:99,142,431...99,183,540
Ensembl chr 7:99,142,450...99,181,783 		JBrowse link
G Cyp2b2 cytochrome P450, family 2, subfamily b, polypeptide 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2B13 mRNA CTD PMID:29950665 NCBI chr 1:83,103,925...83,119,578
Ensembl chr 1:83,103,925...83,119,193 		JBrowse link
G Cyp2c24 cytochrome P450, family 2, subfamily c, polypeptide 24 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2C55 mRNA CTD PMID:29950665 NCBI chr 1:258,074,797...258,139,176
Ensembl chr 1:258,074,860...258,139,176 		JBrowse link
G Cyp2c6v1 cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2C38 mRNA CTD PMID:29950665 NCBI chr 1:147,713,879...147,814,410
Ensembl chr 1:147,713,892...147,888,007 		JBrowse link
G Cyp2c79 cytochrome P450, family 2, subfamily c, polypeptide 79 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2C29 mRNA CTD PMID:29950665 NCBI chr 1:147,236,480...147,307,988 JBrowse link
G Cyp2d1 cytochrome P450, family 2, subfamily d, polypeptide 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2D10 mRNA CTD PMID:29950665 NCBI chr 7:123,625,641...123,630,045
Ensembl chr 7:123,625,590...123,638,765 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 decreases activity
multiple interactions		 EXP Dextran Sulfate results in decreased activity of CYP2E1 protein
[Dextran Sulfate results in decreased activity of CYP2E1 protein] which results in decreased chemical synthesis of 6-hydroxychlorzoxazone		 CTD PMID:28438436 NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542 		JBrowse link
G Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2J9 mRNA CTD PMID:29950665 NCBI chr 5:119,546,458...119,564,843
Ensembl chr 5:119,546,461...119,564,846 		JBrowse link
G Cyp2r1 cytochrome P450, family 2, subfamily r, polypeptide 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2R1 mRNA CTD PMID:29950665 NCBI chr 1:184,060,521...184,106,604
Ensembl chr 1:184,093,920...184,106,200 		JBrowse link
G Cyp2s1 cytochrome P450, family 2, subfamily s, polypeptide 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP2S1 mRNA CTD PMID:29950665 NCBI chr 1:82,595,211...82,610,350
Ensembl chr 1:82,595,211...82,610,350 		JBrowse link
G Cyp3a62 cytochrome P450, family 3, subfamily a, polypeptide 62 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP3A11 mRNA CTD PMID:29950665 NCBI chr12:18,679,809...18,709,397
Ensembl chr12:18,678,594...18,709,397 		JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP3A13 mRNA CTD PMID:29950665 NCBI chr12:19,074,288...19,114,491
Ensembl chr12:19,074,583...19,114,399 		JBrowse link
G Cyp4b1 cytochrome P450, family 4, subfamily b, polypeptide 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP4B1 mRNA CTD PMID:29950665 NCBI chr 5:134,508,728...134,526,103
Ensembl chr 5:134,508,730...134,526,089 		JBrowse link
G Cyp4f1 cytochrome P450, family 4, subfamily f, polypeptide 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CYP4F14 mRNA CTD PMID:29950665 NCBI chr 7:15,179,472...15,191,113
Ensembl chr 7:15,179,467...15,190,796 		JBrowse link
G Cyp4f39 cytochrome P450, family 4, subfamily f, polypeptide 39 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYP4F39 mRNA CTD PMID:29950665 NCBI chr 7:14,435,024...14,514,960
Ensembl chr 7:14,441,476...14,515,212 		JBrowse link
G Cyp7a1 cytochrome P450 family 7 subfamily A member 1 decreases expression ISO Dextran Sulfate results in decreased expression of CYP7A1 mRNA CTD PMID:27580383 NCBI chr 5:19,358,734...19,368,431
Ensembl chr 5:19,358,734...19,368,431 		JBrowse link
G Cyp7b1 cytochrome P450 family 7 subfamily B member 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CYP7B1 mRNA CTD PMID:29950665 NCBI chr 2:102,701,903...102,871,257
Ensembl chr 2:102,701,903...102,871,257 		JBrowse link
G Dbt dihydrolipoamide branched chain transacylase E2 decreases expression
multiple interactions		 ISO Dextran Sulfate results in decreased expression of DBT protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of DBT protein]		 CTD PMID:32272095 NCBI chr 2:219,563,783...219,592,651
Ensembl chr 2:219,563,783...219,592,650 		JBrowse link
G Dcn decorin multiple interactions
increases expression		 ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DCN mRNA; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of DCN protein] CTD PMID:29950665 PMID:32272095 NCBI chr 7:38,742,250...38,782,282
Ensembl chr 7:38,742,051...38,782,323 		JBrowse link
G Ddr2 discoidin domain receptor tyrosine kinase 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DDR2 mRNA CTD PMID:29950665 NCBI chr13:88,311,639...88,436,561
Ensembl chr13:88,317,145...88,436,789 		JBrowse link
G Derl3 derlin 3 increases expression ISO Dextran Sulfate results in increased expression of DERL3 mRNA CTD PMID:23894361 NCBI chr20:13,692,102...13,707,645
Ensembl chr20:13,704,314...13,706,205 		JBrowse link
G Dgkb diacylglycerol kinase, beta multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DGKB mRNA CTD PMID:29950665 NCBI chr 6:57,516,351...58,277,385
Ensembl chr 6:57,516,713...58,277,279 		JBrowse link
G Dgki diacylglycerol kinase, iota multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of DGKI mRNA CTD PMID:29950665 NCBI chr 4:64,365,115...64,831,473
Ensembl chr 4:64,374,342...64,831,473 		JBrowse link
G Dhrs9 dehydrogenase/reductase 9 increases expression ISO Dextran Sulfate results in increased expression of DHRS9 mRNA CTD PMID:23894361 NCBI chr 3:55,623,671...55,645,883
Ensembl chr 3:55,623,634...55,648,325 		JBrowse link
G Dkk2 dickkopf WNT signaling pathway inhibitor 2 multiple interactions ISO [Dextran Sulfate co-treated with Azoxymethane] results in increased expression of DKK2 mRNA; pristimerin inhibits the reaction [[Dextran Sulfate co-treated with Azoxymethane] results in increased expression of DKK2 mRNA] CTD PMID:31715269 NCBI chr 2:237,148,918...237,240,883
Ensembl chr 2:237,148,941...237,241,350 		JBrowse link
G Dlk1 delta like non-canonical Notch ligand 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DLK1 mRNA CTD PMID:29950665 NCBI chr 6:133,576,513...133,583,751
Ensembl chr 6:133,552,821...133,583,751 		JBrowse link
G Dmpk DM1 protein kinase multiple interactions ISO [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of DMPK mRNA CTD PMID:26271895 NCBI chr 1:79,988,096...79,999,358
Ensembl chr 1:79,989,019...79,999,364 		JBrowse link
G Dnajc10 DnaJ heat shock protein family (Hsp40) member C10 increases expression
multiple interactions		 ISO Dextran Sulfate results in increased expression of DNAJC10 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of DNAJC10 protein]		 CTD PMID:32272095 NCBI chr 3:67,538,289...67,578,308
Ensembl chr 3:67,538,289...67,578,306 		JBrowse link
G Dnm1 dynamin 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DNM1 mRNA CTD PMID:29950665 NCBI chr 3:11,338,081...11,382,043
Ensembl chr 3:11,338,083...11,382,043 		JBrowse link
G Dnm3 dynamin 3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DNM3 mRNA CTD PMID:29950665 NCBI chr13:79,906,711...80,379,967
Ensembl chr13:79,910,382...80,379,929 		JBrowse link
G Dok2 docking protein 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DOK2 mRNA CTD PMID:29950665 NCBI chr15:52,449,884...52,455,414
Ensembl chr15:52,451,161...52,456,409 		JBrowse link
G Dpep1 dipeptidase 1 increases expression
multiple interactions		 ISO Dextran Sulfate results in increased expression of DPEP1 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of DPEP1 protein]		 CTD PMID:32272095 NCBI chr19:55,973,447...55,998,830
Ensembl chr19:55,982,740...55,998,208 		JBrowse link
G Dpep2 dipeptidase 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DPEP2 mRNA CTD PMID:29950665 NCBI chr19:37,964,098...37,975,154
Ensembl chr19:37,964,105...37,970,537 		JBrowse link
G Dpyd dihydropyrimidine dehydrogenase multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of DPYD mRNA CTD PMID:29950665 NCBI chr 2:221,823,692...222,694,627
Ensembl chr 2:221,823,687...222,694,627 		JBrowse link
G Drd4 dopamine receptor D4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of DRD4 mRNA CTD PMID:29950665 NCBI chr 1:214,278,296...214,282,818
Ensembl chr 1:214,278,296...214,281,483 		JBrowse link
G Drd5 dopamine receptor D5 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of DRD5 mRNA CTD PMID:29950665 NCBI chr14:77,220,579...77,222,006
Ensembl chr14:77,220,579...77,222,006 		JBrowse link
G Dtx1 deltex E3 ubiquitin ligase 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of DTX1 mRNA CTD PMID:29950665 NCBI chr12:41,383,885...41,415,783
Ensembl chr12:41,385,241...41,414,754 		JBrowse link
G Duoxa2 dual oxidase maturation factor 2 increases expression ISO Dextran Sulfate results in increased expression of DUOXA2 mRNA CTD PMID:23894361 NCBI chr 3:114,236,718...114,240,086
Ensembl chr 3:114,236,718...114,240,086 		JBrowse link
G Dusp1 dual specificity phosphatase 1 multiple interactions ISO DUSP1 protein affects the reaction [Butylated Hydroxyanisole affects the reaction [Dextran Sulfate affects the expression of IL6 protein]]; DUSP1 protein affects the reaction [Butylated Hydroxyanisole affects the reaction [Dextran Sulfate affects the expression of TNF protein]]; DUSP1 protein affects the reaction [Butylated Hydroxyanisole inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]]; DUSP1 protein affects the reaction [Resveratrol affects the reaction [Dextran Sulfate affects the expression of IL6 protein]]; DUSP1 protein affects the reaction [Resveratrol affects the reaction [Dextran Sulfate affects the expression of TNF protein]]; DUSP1 protein affects the reaction [Resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of PTGS2 protein]]; DUSP1 protein affects the susceptibility to [Azoxymethane co-treated with Dextran Sulfate] CTD PMID:30844440 NCBI chr10:16,970,642...16,973,425
Ensembl chr10:16,970,626...16,973,418 		JBrowse link
G Eci1 enoyl-CoA delta isomerase 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ECI1 mRNA CTD PMID:29950665 NCBI chr10:13,797,573...13,810,918
Ensembl chr10:13,797,562...13,810,913 		JBrowse link
G Ecpas Ecm29 proteasome adaptor and scaffold decreases expression
multiple interactions		 ISO Dextran Sulfate results in decreased expression of ECPAS protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ECPAS protein]		 CTD PMID:32272095 NCBI chr 5:75,928,510...76,040,771
Ensembl chr 5:75,931,293...76,039,760 		JBrowse link
G Eda ectodysplasin-A multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of EDA mRNA CTD PMID:29950665 NCBI chr  X:69,730,123...70,222,693
Ensembl chr  X:69,730,242...70,220,329 		JBrowse link
G Eda2r ectodysplasin A2 receptor multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of EDA2R mRNA CTD PMID:29950665 NCBI chr  X:66,560,200...66,602,509
Ensembl chr  X:66,561,286...66,602,506 		JBrowse link
G Edn1 endothelin 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of EDN1 mRNA CTD PMID:29950665 NCBI chr17:22,136,814...22,143,745
Ensembl chr17:22,137,324...22,143,324 		JBrowse link
G Edn2 endothelin 2 increases expression
multiple interactions		 ISO Dextran Sulfate results in increased expression of EDN2 protein
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of EDN2 mRNA		 CTD PMID:16216902 PMID:29950665 NCBI chr 5:139,098,472...139,106,396
Ensembl chr 5:139,100,898...139,105,792 		JBrowse link
G Ednra endothelin receptor type A multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of EDNRA mRNA CTD PMID:29950665 NCBI chr19:33,928,356...33,991,703
Ensembl chr19:33,928,356...33,991,703 		JBrowse link
G Efemp2 EGF containing fibulin extracellular matrix protein 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of EFEMP2 mRNA CTD PMID:29950665 NCBI chr 1:220,853,695...220,861,420
Ensembl chr 1:220,854,403...220,861,420 		JBrowse link
G Efna1 ephrin A1 multiple interactions ISO [Benzo(a)pyrene co-treated with Dextran Sulfate] results in decreased expression of EFNA1 mRNA CTD PMID:26271895 NCBI chr 2:188,588,808...188,596,156
Ensembl chr 2:188,588,796...188,596,222 		JBrowse link
G Ehhadh enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of EHHADH mRNA CTD PMID:29950665 NCBI chr11:82,945,104...82,978,364
Ensembl chr11:82,945,104...82,978,364 		JBrowse link
G Eif2ak2 eukaryotic translation initiation factor 2-alpha kinase 2 multiple interactions
increases phosphorylation		 ISO EIF2AK2 protein affects the reaction [Dextran Sulfate results in increased activity of CASP3 protein]; EIF2AK2 protein affects the reaction [Dextran Sulfate results in increased expression of IL6 mRNA]; EIF2AK2 protein affects the reaction [Dextran Sulfate results in increased expression of NOS2 mRNA]; EIF2AK2 protein affects the reaction [Dextran Sulfate results in increased phosphorylation of RELA protein]; GW 506033X inhibits the reaction [Dextran Sulfate results in increased phosphorylation of EIF2AK2 protein] CTD PMID:27920257 NCBI chr 6:1,428,845...1,466,193
Ensembl chr 6:1,428,834...1,466,201 		JBrowse link
G Eif3a eukaryotic translation initiation factor 3, subunit A multiple interactions ISO [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of EIF3A mRNA CTD PMID:26271895 NCBI chr 1:282,139,809...282,170,017
Ensembl chr 1:282,139,823...282,170,017 		JBrowse link
G Elane elastase, neutrophil expressed multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ELANE mRNA CTD PMID:29950665 NCBI chr 7:12,638,320...12,640,168
Ensembl chr 7:12,638,322...12,640,232 		JBrowse link
G Elmo2 engulfment and cell motility 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ELMO2 mRNA CTD PMID:29950665 NCBI chr 3:161,812,474...161,850,006
Ensembl chr 3:161,812,474...162,003,588 		JBrowse link
G Emc2 ER membrane protein complex subunit 2 multiple interactions
decreases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of EMC2 protein] CTD PMID:32272095 NCBI chr 7:82,338,639...82,377,389
Ensembl chr 7:82,338,663...82,377,109 		JBrowse link
G Eno3 enolase 3 multiple interactions
decreases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of ENO3 protein] CTD PMID:32272095 NCBI chr10:57,278,271...57,283,661
Ensembl chr10:57,278,307...57,283,653 		JBrowse link
G Enpep glutamyl aminopeptidase multiple interactions
increases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in increased expression of ENPEP protein] CTD PMID:32272095 NCBI chr 2:233,667,253...233,743,866
Ensembl chr 2:233,667,254...233,743,866 		JBrowse link
G Entpd5 ectonucleoside triphosphate diphosphohydrolase 5 multiple interactions ISO [Benzo(a)pyrene co-treated with Dextran Sulfate] results in decreased expression of ENTPD5 mRNA CTD PMID:26271895 NCBI chr 6:108,087,677...108,123,811
Ensembl chr 6:108,087,418...108,120,579 		JBrowse link
G Ep300 E1A binding protein p300 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of EP300 mRNA CTD PMID:29950665 NCBI chr 7:122,818,194...122,889,055
Ensembl chr 7:122,818,975...122,861,296 		JBrowse link
G Erbb2 erb-b2 receptor tyrosine kinase 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ERBB2 mRNA CTD PMID:29950665 NCBI chr10:86,367,596...86,391,728
Ensembl chr10:86,367,596...86,391,728 		JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ERBB3 mRNA CTD PMID:29950665 NCBI chr 7:2,989,202...3,010,610
Ensembl chr 7:2,989,340...3,010,350 		JBrowse link
G Erbb4 erb-b2 receptor tyrosine kinase 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ERBB4 mRNA CTD PMID:29950665 NCBI chr 9:75,021,790...76,178,936
Ensembl chr 9:75,021,790...75,528,644 		JBrowse link
G Ereg epiregulin decreases response to substance
increases expression 		ISO EREG protein results in decreased susceptibility to Dextran Sulfate
dextran sodium sulfate increases expression of Ereg protein in colonic mucosa		 CTD PMID:15456865, PMID:20498653 RGD:39457688 NCBI chr14:18,577,620...18,591,395
Ensembl chr14:18,576,355...18,591,394 		JBrowse link
G Esam endothelial cell adhesion molecule multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ESAM mRNA CTD PMID:29950665 NCBI chr 8:39,997,875...40,008,802
Ensembl chr 8:39,997,875...40,008,809 		JBrowse link
G Esr1 estrogen receptor 1 decreases expression
multiple interactions		 ISO Dextran Sulfate results in decreased expression of ESR1 mRNA
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ESR1 mRNA		 CTD PMID:29950665 PMID:30270565 NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796 		JBrowse link
G Esr2 estrogen receptor 2 multiple interactions ISO Dextran Sulfate promotes the reaction [Zearalenone results in increased expression of ESR2 mRNA] CTD PMID:30270565 NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251 		JBrowse link
G Evl Enah/Vasp-like multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of EVL mRNA CTD PMID:29950665 NCBI chr 6:132,470,283...132,590,242
Ensembl chr 6:132,510,757...132,590,241 		JBrowse link
G F10 coagulation factor X multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of F10 mRNA CTD PMID:29950665 NCBI chr16:81,803,169...81,822,476
Ensembl chr16:81,803,110...81,822,716 		JBrowse link
G F13a1 coagulation factor XIII A1 chain multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of F13A1 mRNA CTD PMID:29950665 NCBI chr17:28,504,650...28,680,015
Ensembl chr17:28,504,623...28,680,362 		JBrowse link
G F2r coagulation factor II (thrombin) receptor multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of F2R mRNA CTD PMID:29950665 NCBI chr 2:26,118,760...26,135,340
Ensembl chr 2:26,118,760...26,135,340 		JBrowse link
G F2rl1 F2R like trypsin receptor 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of F2RL1 mRNA CTD PMID:29950665 NCBI chr 2:25,222,324...25,235,275
Ensembl chr 2:25,222,328...25,235,275 		JBrowse link
G F5 coagulation factor V multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of F5 mRNA CTD PMID:29950665 NCBI chr13:82,479,997...82,535,540
Ensembl chr13:82,479,998...82,535,534 		JBrowse link
G Faah fatty acid amide hydrolase multiple interactions ISO [Serotonin co-treated with Dextran Sulfate] results in decreased expression of FAAH protein CTD PMID:30611738 NCBI chr 5:134,852,899...134,872,095
Ensembl chr 5:134,852,875...134,871,775 		JBrowse link
G Faahl fatty-acid amide hydrolase-like multiple interactions ISO [Serotonin co-treated with Dextran Sulfate] results in decreased expression of FAAH protein CTD PMID:30611738 NCBI chr 5:134,330,204...134,349,400
Ensembl chr 5:134,331,929...134,348,995 		JBrowse link
G Fabp4 fatty acid binding protein 4 multiple interactions
increases expression		 ISO [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of FABP4 mRNA; Erianin inhibits the reaction [Dextran Sulfate results in increased expression of FABP4 protein] CTD PMID:26271895 PMID:32272095 NCBI chr 2:93,792,666...93,797,267
Ensembl chr 2:93,792,601...93,797,305 		JBrowse link
G Fabp6 fatty acid binding protein 6 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FABP6 mRNA CTD PMID:29950665 NCBI chr10:29,191,621...29,196,593
Ensembl chr10:29,191,623...29,196,563 		JBrowse link
G Fau FAU, ubiquitin like and ribosomal protein S30 fusion multiple interactions
decreases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of FAU protein] CTD PMID:32272095 NCBI chr 1:221,420,312...221,421,827
Ensembl chr 1:221,420,271...221,421,842 		JBrowse link
G Fbln2 fibulin 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FBLN2 mRNA CTD PMID:29950665 NCBI chr 4:122,835,237...122,895,127
Ensembl chr 4:122,835,436...122,895,121 		JBrowse link
G Fbln5 fibulin 5 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FBLN5 mRNA CTD PMID:29950665 NCBI chr 6:125,644,797...125,723,957
Ensembl chr 6:125,644,804...125,723,944 		JBrowse link
G Fbn1 fibrillin 1 multiple interactions
decreases expression		 ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FBN1 mRNA; Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of FBN1 protein] CTD PMID:29950665 PMID:32272095 NCBI chr 3:117,569,708...117,766,160
Ensembl chr 3:117,569,697...117,766,120 		JBrowse link
G Fcer1g Fc fragment of IgE receptor Ig multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FCER1G mRNA CTD PMID:29950665 NCBI chr13:89,601,894...89,606,326
Ensembl chr13:89,601,896...89,606,326 		JBrowse link
G Fcgr1a Fc fragment of IgG receptor Ia multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FCGR1 mRNA CTD PMID:29950665 NCBI chr 2:198,430,536...198,439,453
Ensembl chr 2:198,430,530...198,458,041 		JBrowse link
G Fcgr2a Fc fragment of IgG receptor IIa multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FCGR3 mRNA CTD PMID:29950665 NCBI chr13:91,146,878...91,163,691
Ensembl chr13:91,168,973...91,198,036
Ensembl chr13:91,168,973...91,198,036 		JBrowse link
G Fcgr2b Fc fragment of IgG receptor IIb multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FCGR2B mRNA CTD PMID:29950665 NCBI chr13:89,329,298...89,343,916
Ensembl chr13:89,327,794...89,433,815 		JBrowse link
G Fcgr3a Fc fragment of IgG receptor IIIa multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FCGR4 mRNA CTD PMID:29950665 NCBI chr13:89,385,775...89,396,047
Ensembl chr13:89,385,859...89,396,051 		JBrowse link
G Fdx1 ferredoxin 1 multiple interactions
decreases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of FDX1 protein] CTD PMID:32272095 NCBI chr 8:56,373,729...56,393,199
Ensembl chr 8:56,373,723...56,393,233 		JBrowse link
G Fermt3 fermitin family member 3 increases expression
multiple interactions		 ISO Dextran Sulfate results in increased expression of FERMT3 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of FERMT3 protein]		 CTD PMID:32272095 NCBI chr 1:222,254,183...222,272,775
Ensembl chr 1:222,254,184...222,272,285 		JBrowse link
G Ffar2 free fatty acid receptor 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FFAR2 mRNA CTD PMID:29950665 NCBI chr 1:89,268,197...89,271,942
Ensembl chr 1:89,268,938...89,269,930 		JBrowse link
G Ffar4 free fatty acid receptor 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FFAR4 mRNA CTD PMID:29950665 NCBI chr 1:256,786,124...256,804,156
Ensembl chr 1:256,786,124...256,804,156 		JBrowse link
G Fgf18 fibroblast growth factor 18 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FGF18 mRNA CTD PMID:29950665 NCBI chr10:18,047,109...18,082,290
Ensembl chr10:18,047,109...18,063,391 		JBrowse link
G Fgf19 fibroblast growth factor 19 multiple interactions ISO Dextran Sulfate results in increased expression of and results in increased secretion of FGF15 protein CTD PMID:27580383 NCBI chr 1:218,058,405...218,061,693
Ensembl chr 1:218,058,405...218,061,693 		JBrowse link
G Fgf2 fibroblast growth factor 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FGF2 mRNA CTD PMID:29950665 NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681 		JBrowse link
G Fgf23 fibroblast growth factor 23 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FGF23 mRNA CTD PMID:29950665 NCBI chr 4:159,622,404...159,630,082
Ensembl chr 4:159,622,404...159,630,082 		JBrowse link
G Fgf8 fibroblast growth factor 8 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FGF8 mRNA CTD PMID:29950665 NCBI chr 1:265,492,949...265,498,965
Ensembl chr 1:265,493,124...265,498,831 		JBrowse link
G Fgf9 fibroblast growth factor 9 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FGF9 mRNA CTD PMID:29950665 NCBI chr15:38,341,657...38,386,945
Ensembl chr15:38,341,089...38,387,316 		JBrowse link
G Fgfr1 Fibroblast growth factor receptor 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FGFR1 mRNA CTD PMID:29950665 NCBI chr16:71,265,390...71,319,046
Ensembl chr16:71,266,248...71,319,449 		JBrowse link
G Fgfr4 fibroblast growth factor receptor 4 increases expression ISO Dextran Sulfate results in increased expression of FGFR4 mRNA CTD PMID:27580383 NCBI chr17:9,990,072...10,004,339
Ensembl chr17:9,990,078...10,004,321 		JBrowse link
G Fhl3 four and a half LIM domains 3 increases expression
multiple interactions		 ISO Dextran Sulfate results in increased expression of FHL3 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of FHL3 protein]		 CTD PMID:32272095 NCBI chr 5:142,688,962...142,696,330
Ensembl chr 5:142,689,026...142,696,383 		JBrowse link
G Flot2 flotillin 2 increases expression
multiple interactions		 ISO Dextran Sulfate results in increased expression of FLOT2 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of FLOT2 protein]		 CTD PMID:32272095 NCBI chr10:65,304,901...65,329,332
Ensembl chr10:65,304,902...65,329,312 		JBrowse link
G Flt1 Fms related receptor tyrosine kinase 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FLT1 mRNA CTD PMID:29950665 NCBI chr12:9,033,993...9,205,886
Ensembl chr12:9,034,308...9,205,905 		JBrowse link
G Flt4 Fms related receptor tyrosine kinase 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FLT4 mRNA CTD PMID:29950665 NCBI chr10:35,078,782...35,120,296
Ensembl chr10:35,078,726...35,121,599 		JBrowse link
G Fmo1 flavin containing dimethylaniline monoxygenase 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FMO1 mRNA CTD PMID:29950665 NCBI chr13:80,712,885...80,745,095
Ensembl chr13:80,712,882...80,745,347 		JBrowse link
G Fmod fibromodulin multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FMOD mRNA CTD PMID:29950665 NCBI chr13:50,874,886...50,885,503
Ensembl chr13:50,873,605...50,885,563 		JBrowse link
G Fn1 fibronectin 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FN1 mRNA CTD PMID:29950665 NCBI chr 9:78,900,111...78,969,018
Ensembl chr 9:78,900,103...78,969,078 		JBrowse link
G Fos Fos proto-oncogene, AP-1 transcription factor subunit multiple interactions ISO Dextran Sulfate promotes the reaction [Capsaicin results in increased expression of FOS protein]; GRK6 mutant form promotes the reaction [Dextran Sulfate promotes the reaction [Capsaicin results in increased expression of FOS protein]] CTD PMID:18687398 NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299 		JBrowse link
G Fosl1 FOS like 1, AP-1 transcription factor subunit increases expression ISO Dextran Sulfate results in increased expression of FOSL1 protein CTD PMID:20025956 NCBI chr 1:220,826,560...220,835,066
Ensembl chr 1:220,826,560...220,835,066 		JBrowse link
G Foxa2 forkhead box A2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FOXA2 mRNA CTD PMID:29950665 NCBI chr 3:142,383,084...142,387,493
Ensembl chr 3:142,383,278...142,387,481 		JBrowse link
G Foxa3 forkhead box A3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FOXA3 mRNA CTD PMID:29950665 NCBI chr 1:79,921,292...79,930,219
Ensembl chr 1:79,920,752...79,930,263 		JBrowse link
G Foxo3 forkhead box O3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FOXO3 mRNA CTD PMID:29950665 NCBI chr20:46,428,078...46,519,156
Ensembl chr20:46,428,124...46,519,144 		JBrowse link
G Foxo4 forkhead box O4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FOXO4 mRNA CTD PMID:29950665 NCBI chr  X:71,155,284...71,162,158
Ensembl chr  X:71,155,601...71,162,158 		JBrowse link
G Foxp3 forkhead box P3 increases methylation
increases expression
multiple interactions		 ISO
EXP		 Dextran Sulfate results in increased methylation of FOXP3 gene
Dextran Sulfate results in increased expression of FOXP3 mRNA
kappa-casein glycomacropeptide inhibits the reaction [Dextran Sulfate results in increased expression of FOXP3 mRNA]
Chlorpyrifos inhibits the reaction [Dextran Sulfate results in increased expression of FOXP3 mRNA]; Tetrachlorodibenzodioxin inhibits the reaction [Dextran Sulfate results in increased methylation of FOXP3 gene]		 CTD PMID:20881082 PMID:21858153 PMID:31807802 NCBI chr  X:15,753,175...15,768,648
Ensembl chr  X:15,753,175...15,768,522 		JBrowse link
G Fpgt fucose-1-phosphate guanylyltransferase multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FPGT mRNA CTD PMID:29950665 NCBI chr 2:261,382,015...261,402,950
Ensembl chr 2:261,382,060...261,402,903 		JBrowse link
G Fpr1 formyl peptide receptor 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FPR1 mRNA CTD PMID:29950665 NCBI chr 1:59,759,025...59,767,258
Ensembl chr 1:59,765,835...59,767,042 		JBrowse link
G Fpr2 formyl peptide receptor 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FPR2 mRNA CTD PMID:29950665 NCBI chr 1:59,800,558...59,809,507
Ensembl chr 1:59,800,984...59,802,401 		JBrowse link
G Fpr3 formyl peptide receptor 3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FPR3 mRNA CTD PMID:29950665 NCBI chr 1:116,152,526...116,161,873
Ensembl chr 1:116,152,667...116,153,722 		JBrowse link
G Fshr follicle stimulating hormone receptor multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FSHR mRNA CTD PMID:29950665 NCBI chr 6:12,796,383...12,997,817
Ensembl chr 6:12,796,383...12,997,817 		JBrowse link
G Fst follistatin multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FST mRNA CTD PMID:29950665 NCBI chr 2:46,537,589...46,544,813
Ensembl chr 2:46,538,700...46,544,457 		JBrowse link
G Fstl3 follistatin like 3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FSTL3 mRNA CTD PMID:29950665 NCBI chr 7:12,806,031...12,810,556
Ensembl chr 7:12,804,919...12,810,570 		JBrowse link
G Fxyd1 FXYD domain-containing ion transport regulator 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FXYD1 mRNA CTD PMID:29950665 NCBI chr 1:89,484,197...89,488,279
Ensembl chr 1:89,484,199...89,488,223 		JBrowse link
G Fxyd3 FXYD domain-containing ion transport regulator 3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FXYD3 mRNA CTD PMID:29950665 NCBI chr 1:89,502,561...89,510,146
Ensembl chr 1:89,502,562...89,509,343 		JBrowse link
G Fxyd4 FXYD domain-containing ion transport regulator 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FXYD4 mRNA CTD PMID:29950665 NCBI chr 4:149,984,206...149,988,744
Ensembl chr 4:149,984,206...149,988,295 		JBrowse link
G Fyn FYN proto-oncogene, Src family tyrosine kinase multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FYN mRNA CTD PMID:29950665 NCBI chr20:44,436,354...44,630,316
Ensembl chr20:44,436,403...44,630,317 		JBrowse link
G Fzd1 frizzled class receptor 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FZD1 mRNA CTD PMID:29950665 NCBI chr 4:26,470,864...26,475,262
Ensembl chr 4:26,470,864...26,475,262 		JBrowse link
G Fzd4 frizzled class receptor 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FZD4 mRNA CTD PMID:29950665 NCBI chr 1:153,589,471...153,598,376
Ensembl chr 1:153,589,471...153,598,375 		JBrowse link
G Fzd5 frizzled class receptor 5 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FZD5 mRNA CTD PMID:29950665 NCBI chr 9:71,443,784...71,445,541
Ensembl chr 9:71,443,588...71,445,739 		JBrowse link
G Fzd6 frizzled class receptor 6 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FZD6 mRNA CTD PMID:29950665 NCBI chr 7:77,898,329...77,931,034
Ensembl chr 7:77,899,322...77,931,029 		JBrowse link
G Fzd7 frizzled class receptor 7 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FZD7 mRNA CTD PMID:29950665 NCBI chr 9:66,305,731...66,308,550
Ensembl chr 9:66,305,731...66,308,550 		JBrowse link
G Fzd8 frizzled class receptor 8 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of FZD8 mRNA CTD PMID:29950665 NCBI chr17:62,259,910...62,267,239
Ensembl chr17:62,262,129...62,265,113 		JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of G6PC1 mRNA CTD PMID:29950665 NCBI chr10:89,286,009...89,296,213
Ensembl chr10:89,285,855...89,296,213 		JBrowse link
G Gabbr1 gamma-aminobutyric acid type B receptor subunit 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GABBR1 mRNA CTD PMID:29950665 NCBI chr20:1,955,344...1,984,907
Ensembl chr20:1,955,359...1,984,863 		JBrowse link
G Gabra2 gamma-aminobutyric acid type A receptor subunit alpha 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GABRA2 mRNA CTD PMID:29950665 NCBI chr14:39,662,411...39,801,082
Ensembl chr14:39,661,968...39,798,302 		JBrowse link
G Gabra5 gamma-aminobutyric acid type A receptor subunit alpha 5 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GABRA5 mRNA CTD PMID:29950665 NCBI chr 1:112,833,941...112,947,482
Ensembl chr 1:112,833,944...112,947,451 		JBrowse link
G Gabrb2 gamma-aminobutyric acid type A receptor subunit beta 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GABRB2 mRNA CTD PMID:29950665 NCBI chr10:27,973,694...28,193,072
Ensembl chr10:27,973,681...28,187,565 		JBrowse link
G Gabrd gamma-aminobutyric acid type A receptor subunit delta multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GABRD mRNA CTD PMID:29950665 NCBI chr 5:172,797,478...172,809,374
Ensembl chr 5:172,797,450...172,809,353 		JBrowse link
G Gad1 glutamate decarboxylase 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GAD1 mRNA CTD PMID:29950665 NCBI chr 3:56,861,440...56,902,139
Ensembl chr 3:56,861,396...56,902,157 		JBrowse link
G Gale UDP-galactose-4-epimerase multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GALE mRNA CTD PMID:29950665 NCBI chr 5:154,310,453...154,314,959
Ensembl chr 5:154,310,453...154,314,955 		JBrowse link
G Galk2 galactokinase 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GALK2 mRNA CTD PMID:29950665 NCBI chr 3:118,137,097...118,268,838
Ensembl chr 3:118,136,838...118,268,836 		JBrowse link
G Galnt10 polypeptide N-acetylgalactosaminyltransferase 10 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GALNT10 mRNA CTD PMID:29950665 NCBI chr10:43,067,316...43,208,992
Ensembl chr10:43,067,299...43,210,427 		JBrowse link
G Galnt12 polypeptide N-acetylgalactosaminyltransferase 12 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GALNT12 mRNA CTD PMID:29950665 NCBI chr 5:62,718,733...62,751,345
Ensembl chr 5:62,718,787...62,750,145 		JBrowse link
G Galnt15 polypeptide N-acetylgalactosaminyltransferase 15 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GALNT15 mRNA CTD PMID:29950665 NCBI chr16:8,127,599...8,178,101
Ensembl chr16:8,128,689...8,177,841 		JBrowse link
G Galnt16 polypeptide N-acetylgalactosaminyltransferase 16 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GALNT16 mRNA CTD PMID:29950665 NCBI chr 6:104,069,853...104,250,177
Ensembl chr 6:104,068,547...104,250,174 		JBrowse link
G Galnt18 polypeptide N-acetylgalactosaminyltransferase 18 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GALNT18 mRNA CTD PMID:29950665 NCBI chr 1:176,296,186...176,607,466
Ensembl chr 1:176,296,193...176,607,466 		JBrowse link
G Galnt2 polypeptide N-acetylgalactosaminyltransferase 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GALNT2 mRNA CTD PMID:29950665 NCBI chr19:57,043,858...57,115,123
Ensembl chr19:57,047,830...57,115,132 		JBrowse link
G Galnt4 polypeptide N-acetylgalactosaminyltransferase 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GALNT4 mRNA CTD PMID:29950665 NCBI chr 7:41,305,437...41,309,621 JBrowse link
G Galnt5 polypeptide N-acetylgalactosaminyltransferase 5 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GALNT5 mRNA CTD PMID:29950665 NCBI chr 3:44,025,964...44,072,073
Ensembl chr 3:44,025,300...44,074,678 		JBrowse link
G Galnt6 polypeptide N-acetylgalactosaminyltransferase 6 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GALNT6 mRNA CTD PMID:29950665 NCBI chr 7:142,322,172...142,364,281
Ensembl chr 7:142,322,172...142,352,382 		JBrowse link
G Galnt7 polypeptide N-acetylgalactosaminyltransferase 7 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GALNT7 mRNA CTD PMID:29950665 NCBI chr16:35,935,059...36,062,734
Ensembl chr16:35,934,970...36,062,719 		JBrowse link
G Galntl6 polypeptide N-acetylgalactosaminyltransferase-like 6 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GALNTL6 mRNA CTD PMID:29950665 NCBI chr16:34,551,052...35,803,840
Ensembl chr16:35,573,058...35,802,979 		JBrowse link
G Gast gastrin decreases response to substance
multiple interactions		 ISO GAST protein modified form results in decreased susceptibility to Dextran Sulfate
[titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GAST mRNA		 CTD PMID:16618411 PMID:29950665 NCBI chr10:88,245,532...88,248,485
Ensembl chr10:88,245,532...88,248,484 		JBrowse link
G Gata2 GATA binding protein 2 multiple interactions ISO [Benzo(a)pyrene co-treated with Dextran Sulfate] results in increased expression of GATA2 mRNA CTD PMID:26271895 NCBI chr 4:120,129,028...120,142,490
Ensembl chr 4:120,133,713...120,142,488 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GCLC mRNA CTD PMID:29950665 NCBI chr 8:85,059,051...85,097,471
Ensembl chr 8:85,059,051...85,097,468 		JBrowse link
G Gclm glutamate cysteine ligase, modifier subunit multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GCLM mRNA CTD PMID:29950665 NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874 		JBrowse link
G Gcnt3 glucosaminyl (N-acetyl) transferase 3, mucin type multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GCNT3 mRNA CTD PMID:29950665 NCBI chr 8:76,449,078...76,459,431
Ensembl chr 8:76,449,081...76,452,554 		JBrowse link
G Gfpt1 glutamine fructose-6-phosphate transaminase 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GFPT1 mRNA CTD PMID:29950665 NCBI chr 4:118,852,046...118,901,583
Ensembl chr 4:118,852,062...118,901,591 		JBrowse link
G Gfpt2 glutamine-fructose-6-phosphate transaminase 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GFPT2 mRNA CTD PMID:29950665 NCBI chr10:35,279,237...35,325,506
Ensembl chr10:35,279,236...35,325,508 		JBrowse link
G Gfus GDP-L-fucose synthase multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GFUS mRNA CTD PMID:29950665 NCBI chr 7:116,958,427...116,963,281
Ensembl chr 7:116,958,392...116,963,295 		JBrowse link
G Ggct gamma-glutamyl cyclotransferase multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GGCT mRNA CTD PMID:29950665 NCBI chr 4:85,186,644...85,192,857
Ensembl chr 4:85,186,644...85,192,834 		JBrowse link
G Gh1 growth hormone 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GH mRNA CTD PMID:29950665 NCBI chr10:94,486,204...94,488,181
Ensembl chr10:94,486,205...94,488,180 		JBrowse link
G Ghrl ghrelin and obestatin prepropeptide multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GHRL mRNA CTD PMID:29950665 NCBI chr 4:145,674,157...145,678,066
Ensembl chr 4:145,674,157...145,678,066 		JBrowse link
G Glb1 galactosidase, beta 1 increases expression
multiple interactions		 ISO Dextran Sulfate results in increased expression of GLB1 protein
Erianin inhibits the reaction [Dextran Sulfate results in increased expression of GLB1 protein]		 CTD PMID:32272095 NCBI chr 8:122,439,328...122,511,939
Ensembl chr 8:122,439,328...122,511,939 		JBrowse link
G Gli3 GLI family zinc finger 3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GLI3 mRNA CTD PMID:29950665 NCBI chr17:52,294,942...52,569,036
Ensembl chr17:52,294,942...52,569,036 		JBrowse link
G Glp1r glucagon-like peptide 1 receptor multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GLP1R mRNA CTD PMID:29950665 NCBI chr20:9,586,075...9,626,228
Ensembl chr20:9,586,075...9,626,228 		JBrowse link
G Gls glutaminase decreases expression
multiple interactions		 ISO Dextran Sulfate results in decreased expression of GLS protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of GLS protein]		 CTD PMID:32272095 NCBI chr 9:54,212,622...54,284,879
Ensembl chr 9:54,212,767...54,284,872 		JBrowse link
G Gmds GDP-mannose 4, 6-dehydratase multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GMDS mRNA CTD PMID:29950665 NCBI chr17:33,408,722...33,938,086
Ensembl chr17:33,408,722...33,938,085 		JBrowse link
G Gna11 G protein subunit alpha 11 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GNA11 mRNA CTD PMID:29950665 NCBI chr 7:11,033,400...11,047,284
Ensembl chr 7:11,033,317...11,047,437 		JBrowse link
G Gna12 G protein subunit alpha 12 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GNA12 mRNA CTD PMID:29950665 NCBI chr12:15,890,202...15,971,212
Ensembl chr12:15,890,170...15,971,212 		JBrowse link
G Gna14 G protein subunit alpha 14 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GNA14 mRNA CTD PMID:29950665 NCBI chr 1:235,165,775...235,347,986
Ensembl chr 1:235,166,718...235,347,937 		JBrowse link
G Gna15 G protein subunit alpha 15 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GNA15 mRNA CTD PMID:29950665 NCBI chr 7:11,054,249...11,075,152
Ensembl chr 7:11,054,333...11,077,251 		JBrowse link
G Gnaz G protein subunit alpha z multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GNAZ mRNA CTD PMID:29950665 NCBI chr20:14,593,072...14,644,020
Ensembl chr20:14,593,819...14,620,019 		JBrowse link
G Gnb3 G protein subunit beta 3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GNB3 mRNA CTD PMID:29950665 NCBI chr 4:157,352,558...157,359,237
Ensembl chr 4:157,352,372...157,358,262 		JBrowse link
G Gne glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GNE mRNA CTD PMID:29950665 NCBI chr 5:59,511,738...59,553,421
Ensembl chr 5:59,512,872...59,553,416 		JBrowse link
G Gng4 G protein subunit gamma 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GNG4 mRNA CTD PMID:29950665 NCBI chr17:90,266,571...90,316,278
Ensembl chr17:90,266,794...90,315,492 		JBrowse link
G Gng7 G protein subunit gamma 7 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GNG7 mRNA CTD PMID:29950665 NCBI chr 7:11,565,740...11,629,519
Ensembl chr 7:11,582,984...11,628,929 		JBrowse link
G Gng8 G protein subunit gamma 8 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GNG8 mRNA CTD PMID:29950665 NCBI chr 1:78,818,360...78,822,224
Ensembl chr 1:78,818,404...78,822,224 		JBrowse link
G Gngt2 G protein subunit gamma transducin 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GNGT2 mRNA CTD PMID:29950665 NCBI chr10:83,654,321...83,658,601
Ensembl chr10:83,655,460...83,658,589 		JBrowse link
G Gnpnat1 glucosamine-phosphate N-acetyltransferase 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GNPNAT1 mRNA CTD PMID:29950665 NCBI chr15:19,721,292...19,734,032
Ensembl chr15:19,721,293...19,733,967 		JBrowse link
G Gpbar1 G protein-coupled bile acid receptor 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPBAR1 mRNA CTD PMID:29950665 NCBI chr 9:81,555,914...81,560,931
Ensembl chr 9:81,559,605...81,560,594 		JBrowse link
G Gpc4 glypican 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPC4 mRNA CTD PMID:29950665 NCBI chr  X:139,354,325...139,464,876
Ensembl chr  X:139,354,155...139,464,798 		JBrowse link
G Gpnmb glycoprotein nmb increases expression ISO Dextran Sulfate results in increased expression of GPNMB mRNA CTD PMID:23894361 NCBI chr 4:78,694,447...78,715,685
Ensembl chr 4:78,694,447...78,715,683 		JBrowse link
G Gpr119 G protein-coupled receptor 119 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of GPR119 mRNA CTD PMID:29950665 NCBI chr  X:135,515,545...135,521,598
Ensembl chr  X:135,515,545...135,521,598 		JBrowse link
G Gpr137b G protein-coupled receptor 137B multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPR137B mRNA CTD PMID:29950665 NCBI chr17:90,670,852...90,709,003
Ensembl chr17:90,670,872...90,746,804 		JBrowse link
G Gpr149 G protein-coupled receptor 149 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPR149 mRNA CTD PMID:29950665 NCBI chr 2:152,838,836...152,912,027
Ensembl chr 2:152,839,117...152,911,553 		JBrowse link
G Gpr15 G protein-coupled receptor 15 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GPR15 mRNA CTD PMID:29950665 NCBI chr11:43,992,739...44,004,189
Ensembl chr11:44,001,579...44,003,664 		JBrowse link
G Gpr152 G protein-coupled receptor 152 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GPR152 mRNA CTD PMID:29950665 NCBI chr 1:219,389,418...219,394,124
Ensembl chr 1:219,390,523...219,392,478 		JBrowse link
G Gpr17 G protein-coupled receptor 17 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GPR17 mRNA CTD PMID:29950665 NCBI chr18:24,733,306...24,739,194
Ensembl chr18:24,734,330...24,735,349 		JBrowse link
G Gpr176 G protein-coupled receptor 176 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPR176 mRNA CTD PMID:29950665 NCBI chr 3:110,042,853...110,140,756
Ensembl chr 3:110,042,853...110,140,756 		JBrowse link
G Gpr20 G protein-coupled receptor 20 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPR20 mRNA CTD PMID:29950665 NCBI chr 7:114,943,675...114,953,977
Ensembl chr 7:114,944,282...114,945,344 		JBrowse link
G Gpr27 G protein-coupled receptor 27 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GPR27 mRNA CTD PMID:29950665 NCBI chr 4:132,137,793...132,138,926
Ensembl chr 4:132,137,793...132,138,926 		JBrowse link
G Gpr37l1 G protein-coupled receptor 37-like 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GPR37L1 mRNA CTD PMID:29950665 NCBI chr13:51,985,698...51,992,547
Ensembl chr13:51,985,684...51,992,693 		JBrowse link
G Gpr39 G protein-coupled receptor 39 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GPR39 mRNA CTD PMID:29950665 NCBI chr13:42,008,642...42,220,737
Ensembl chr13:42,008,842...42,009,738 		JBrowse link
G Gpr4 G protein-coupled receptor 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPR4 mRNA CTD PMID:29950665 NCBI chr 1:80,125,639...80,136,786
Ensembl chr 1:80,135,391...80,136,880 		JBrowse link
G Gpr50 G protein-coupled receptor 50 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GPR50 mRNA CTD PMID:29950665 NCBI chr17:36,771,578...36,776,225
Ensembl chr17:36,771,639...36,776,225 		JBrowse link
G Gpr68 G protein-coupled receptor 68 multiple interactions ISO [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GPR68 mRNA CTD PMID:28174749 NCBI chr 6:124,874,151...124,903,949
Ensembl chr 6:124,874,151...124,876,710 		JBrowse link
G Gpr83 G protein-coupled receptor 83 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPR83 mRNA CTD PMID:29950665 NCBI chr 8:13,365,583...13,376,071
Ensembl chr 8:13,365,583...13,376,070 		JBrowse link
G Gpr85 G protein-coupled receptor 85 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPR85 mRNA CTD PMID:29950665 NCBI chr 4:40,377,705...40,387,147
Ensembl chr 4:40,381,685...40,385,349 		JBrowse link
G Gpr88 G-protein coupled receptor 88 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPR88 mRNA CTD PMID:29950665 NCBI chr 2:219,258,346...219,263,819
Ensembl chr 2:219,258,347...219,262,901 		JBrowse link
G Gprc5b G protein-coupled receptor, class C, group 5, member B multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPRC5B mRNA CTD PMID:29950665 NCBI chr 1:188,688,743...188,713,724
Ensembl chr 1:188,688,743...188,713,280 		JBrowse link
G Gprc5d G protein-coupled receptor, class C, group 5, member D multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPRC5D mRNA CTD PMID:29950665 NCBI chr 4:168,872,897...168,884,925
Ensembl chr 4:168,872,897...168,884,886 		JBrowse link
G Gpx3 glutathione peroxidase 3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPX3 mRNA CTD PMID:29950665 NCBI chr10:40,247,436...40,255,423
Ensembl chr10:40,247,436...40,255,422 		JBrowse link
G Gpx7 glutathione peroxidase 7 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPX7 mRNA CTD PMID:29950665 NCBI chr 5:128,001,766...128,009,610
Ensembl chr 5:128,001,761...128,009,735 		JBrowse link
G Gpx8 glutathione peroxidase 8 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GPX8 mRNA CTD PMID:29950665 NCBI chr 2:44,903,337...44,907,046
Ensembl chr 2:44,903,337...44,907,030 		JBrowse link
G Grb2 growth factor receptor bound protein 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GRB2 mRNA CTD PMID:29950665 NCBI chr10:104,193,953...104,263,071
Ensembl chr10:104,193,955...104,263,071 		JBrowse link
G Grb7 growth factor receptor bound protein 7 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GRB7 mRNA CTD PMID:29950665 NCBI chr10:86,393,186...86,408,893
Ensembl chr10:86,399,827...86,409,348 		JBrowse link
G Grem1 gremlin 1, DAN family BMP antagonist multiple interactions
increases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in increased expression of GREM1 protein] CTD PMID:32272095 NCBI chr 3:105,203,309...105,214,989
Ensembl chr 3:105,203,309...105,214,989 		JBrowse link
G Grik4 glutamate ionotropic receptor kainate type subunit 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GRIK4 mRNA CTD PMID:29950665 NCBI chr 8:46,804,134...47,237,546
Ensembl chr 8:46,806,147...47,094,352 		JBrowse link
G Grin2b glutamate ionotropic receptor NMDA type subunit 2B multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GRIN2B mRNA CTD PMID:29950665 NCBI chr 4:169,541,620...170,000,216
Ensembl chr 4:169,560,387...169,999,873 		JBrowse link
G Grin2d glutamate ionotropic receptor NMDA type subunit 2D multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GRIN2D mRNA CTD PMID:29950665 NCBI chr 1:101,819,068...101,859,146
Ensembl chr 1:101,820,461...101,856,881 		JBrowse link
G Grk3 G protein-coupled receptor kinase 3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GRK3 mRNA CTD PMID:29950665 NCBI chr12:49,626,871...49,750,389
Ensembl chr12:49,626,871...49,746,272 		JBrowse link
G Grk6 G protein-coupled receptor kinase 6 multiple interactions
decreases response to substance		 ISO GRK6 mutant form promotes the reaction [Dextran Sulfate promotes the reaction [Capsaicin results in increased expression of FOS protein]]
GRK6 results in decreased susceptibility to Dextran Sulfate		 CTD PMID:18687398 NCBI chr17:9,705,917...9,721,921
Ensembl chr17:9,703,453...9,721,574 		JBrowse link
G Grm4 glutamate metabotropic receptor 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GRM4 mRNA CTD PMID:29950665 NCBI chr20:6,745,682...6,791,521
Ensembl chr20:6,745,682...6,791,519 		JBrowse link
G Grpr gastrin releasing peptide receptor multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GRPR mRNA CTD PMID:29950665 NCBI chr  X:32,746,259...32,786,266
Ensembl chr  X:32,745,873...32,786,359 		JBrowse link
G Gsn gelsolin multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GSN mRNA CTD PMID:29950665 NCBI chr 3:14,456,106...14,508,922
Ensembl chr 3:14,467,330...14,508,911 		JBrowse link
G Gss glutathione synthetase multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GSS mRNA CTD PMID:29950665 NCBI chr 3:151,076,254...151,106,557
Ensembl chr 3:151,076,254...151,106,557 		JBrowse link
G Gstk1 glutathione S-transferase kappa 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GSTK1 mRNA CTD PMID:29950665 NCBI chr 4:71,621,777...71,626,096
Ensembl chr 4:71,621,729...71,626,107 		JBrowse link
G Gstm5 glutathione S-transferase, mu 5 multiple interactions
decreases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of GSTM3 protein] CTD PMID:32272095 NCBI chr 2:210,685,338...210,688,133
Ensembl chr 2:210,685,197...210,688,272 		JBrowse link
G Gsto1 glutathione S-transferase omega 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GSTO1 mRNA CTD PMID:29950665 NCBI chr 1:267,607,437...267,617,387
Ensembl chr 1:267,607,418...267,617,387 		JBrowse link
G Gsto2 glutathione S-transferase omega 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GSTO2 mRNA CTD PMID:29950665 NCBI chr 1:267,617,517...267,640,455
Ensembl chr 1:271,229,036...271,243,517
Ensembl chr 1:271,229,036...271,243,517 		JBrowse link
G Gstt2 glutathione S-transferase, theta 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GSTT2 mRNA CTD PMID:29950665 NCBI chr20:13,760,810...13,764,481
Ensembl chr20:13,760,810...13,764,475 		JBrowse link
G Guca1b guanylate cyclase activator 1B multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GUCA1B mRNA CTD PMID:29950665 NCBI chr 9:15,621,083...15,629,017
Ensembl chr 9:15,621,083...15,629,017 		JBrowse link
G Gucy2f guanylate cyclase 2F multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of GUCY2F mRNA CTD PMID:29950665 NCBI chr  X:113,372,240...113,474,210
Ensembl chr  X:113,372,240...113,474,164 		JBrowse link
G Guk1 guanylate kinase 1 multiple interactions
decreases expression		 ISO Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of GUK1 protein] CTD PMID:32272095 NCBI chr10:45,535,617...45,552,455
Ensembl chr10:45,535,627...45,543,897 		JBrowse link
G Gzma granzyme A multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of GZMA mRNA CTD PMID:29950665 NCBI chr 2:44,968,846...44,981,436
Ensembl chr 2:44,968,765...44,981,458 		JBrowse link
G Hadh hydroxyacyl-CoA dehydrogenase decreases expression
multiple interactions		 ISO Dextran Sulfate results in decreased expression of HADH protein
Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of HADH protein]		 CTD PMID:32272095 NCBI chr 2:236,353,445...236,395,067
Ensembl chr 2:236,353,445...236,395,067 		JBrowse link
G Hadhb hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HADHB mRNA CTD PMID:29950665 NCBI chr 6:27,555,408...27,589,539
Ensembl chr 6:27,555,412...27,582,995 		JBrowse link
G Hcar2 hydroxycarboxylic acid receptor 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HCAR2 mRNA CTD PMID:29950665 NCBI chr12:38,160,464...38,161,546
Ensembl chr12:38,160,464...38,161,546 		JBrowse link
G Hcn2 hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HCN2 mRNA CTD PMID:29950665 NCBI chr 7:12,851,730...12,870,087
Ensembl chr 7:12,851,739...12,874,215 		JBrowse link
G Hcn3 hyperpolarization-activated cyclic nucleotide-gated potassium channel 3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HCN3 mRNA CTD PMID:29950665 NCBI chr 2:188,458,851...188,471,916
Ensembl chr 2:188,454,853...188,471,988 		JBrowse link
G Hcn4 hyperpolarization activated cyclic nucleotide-gated potassium channel 4 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HCN4 mRNA CTD PMID:29950665 NCBI chr 8:63,599,907...63,637,327
Ensembl chr 8:63,600,663...63,639,654 		JBrowse link
G Heph hephaestin multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HEPH mRNA CTD PMID:29950665 NCBI chr  X:65,377,313...65,658,479
Ensembl chr  X:65,563,122...65,658,516 		JBrowse link
G Hes1 hes family bHLH transcription factor 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] affects the expression of HES1 mRNA CTD PMID:29950665 NCBI chr11:74,312,837...74,315,249
Ensembl chr11:74,312,806...74,315,248 		JBrowse link
G Hif1a hypoxia inducible factor 1 subunit alpha increases expression
multiple interactions		 ISO Dextran Sulfate results in increased expression of HIF1A protein
resveratrol inhibits the reaction [Dextran Sulfate results in increased expression of HIF1A protein]		 CTD PMID:26074695 NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052 		JBrowse link
G Hk3 hexokinase 3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HK3 mRNA CTD PMID:29950665 NCBI chr17:10,134,726...10,152,976
Ensembl chr17:10,137,974...10,152,956 		JBrowse link
G Hmgb1 high mobility group box 1 multiple interactions ISO 15,16-dihydrotanshinone I inhibits the reaction [Dextran Sulfate results in increased expression of and results in increased secretion of HMGB1 protein]; Dextran Sulfate results in increased expression of and results in increased secretion of HMGB1 protein CTD PMID:29496522 NCBI chr12:7,082,529...7,090,246
Ensembl chr16:37,500,017...37,502,237 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions
decreases expression		 ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HMOX1 mRNA; tussilagone inhibits the reaction [Dextran Sulfate results in decreased expression of HMOX1 mRNA]; tussilagone inhibits the reaction [Dextran Sulfate results in decreased expression of HMOX1 protein]
Dextran Sulfate results in decreased expression of HMOX1 mRNA; Dextran Sulfate results in decreased expression of HMOX1 protein		 CTD PMID:29950665 PMID:30142311 NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456 		JBrowse link
G Hnf1a HNF1 homeobox A increases expression
multiple interactions		 ISO Dextran Sulfate results in increased expression of HNF1A protein
6-formylindolo(3,2-b)carbazole inhibits the reaction [Dextran Sulfate results in increased expression of HNF1A protein]; [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HNF1A mRNA		 CTD PMID:29680209 PMID:29950665 NCBI chr12:47,407,811...47,433,342
Ensembl chr12:47,407,811...47,433,342 		JBrowse link
G Hnf1b HNF1 homeobox B multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HNF1B mRNA CTD PMID:29950665 NCBI chr10:71,159,863...71,218,902
Ensembl chr10:71,159,869...71,218,902 		JBrowse link
G Hnf4a hepatocyte nuclear factor 4, alpha multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HNF4A mRNA CTD PMID:29950665 NCBI chr 3:159,902,441...159,965,003
Ensembl chr 3:159,902,441...159,965,003 		JBrowse link
G Hnf4g hepatocyte nuclear factor 4, gamma multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HNF4G mRNA CTD PMID:29950665 NCBI chr 2:100,225,880...100,372,710
Ensembl chr 2:100,225,888...100,372,252 		JBrowse link
G Hp haptoglobin multiple interactions
increases expression		 ISO Chlorpyrifos promotes the reaction [Dextran Sulfate results in increased expression of HP protein] CTD PMID:31807802 NCBI chr19:42,096,255...42,100,805
Ensembl chr19:42,097,995...42,100,804 		JBrowse link
G Hpgd 15-hydroxyprostaglandin dehydrogenase multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HPGD mRNA CTD PMID:29950665 NCBI chr16:37,457,134...37,495,758
Ensembl chr16:37,457,135...37,495,758 		JBrowse link
G Hrh3 histamine receptor H3 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HRH3 mRNA CTD PMID:29950665 NCBI chr 3:175,474,310...175,479,395
Ensembl chr 3:175,473,078...175,479,395 		JBrowse link
G Hsd11b1 hydroxysteroid 11-beta dehydrogenase 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HSD11B1 mRNA CTD PMID:29950665 NCBI chr13:111,946,626...111,996,536
Ensembl chr13:111,926,442...111,972,603 		JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HSD11B2 mRNA CTD PMID:29950665 NCBI chr19:37,476,083...37,481,326
Ensembl chr19:37,476,095...37,481,307 		JBrowse link
G Hsd17b1 hydroxysteroid (17-beta) dehydrogenase 1 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HSD17B1 mRNA CTD PMID:29950665 NCBI chr10:88,987,558...88,989,758
Ensembl chr10:88,987,558...88,989,757 		JBrowse link
G Hsd17b6 hydroxysteroid (17-beta) dehydrogenase 6 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of HSD17B6 mRNA CTD PMID:29950665 NCBI chr 7:2,412,370...2,431,249
Ensembl chr 7:2,412,363...2,431,197
Ensembl chr13:2,412,363...2,431,197 		JBrowse link
G Hsp90aa1 heat shock protein 90 alpha family class A member 1 multiple interactions
increases expression		 EXP tripterine inhibits the reaction [Dextran Sulfate results in increased expression of HSP90AA1 mRNA] CTD PMID:32470352 NCBI chr 6:135,107,262...135,112,793
Ensembl chr 6:135,107,271...135,112,775 		JBrowse link
G Hsp90ab1 heat shock protein 90 alpha family class B member 1 multiple interactions
increases expression		 EXP tripterine inhibits the reaction [Dextran Sulfate results in increased expression of HSP90AB1 protein] CTD PMID:32470352 NCBI chr 9:17,817,791...17,823,163
Ensembl chr 9:17,817,721...17,823,243 		JBrowse link
G Hspa1a heat shock protein family A (Hsp70) member 1A multiple interactions ISO [Benzo(a)pyrene co-treated with Dextran Sulfate] results in decreased expression of HSPA1A mRNA CTD PMID:26271895 NCBI chr20:4,875,834...4,881,751
Ensembl chr20:4,877,324...4,879,779 		JBrowse link
G Hspa1b heat shock protein family A (Hsp70) member 1B multiple interactions ISO [Benzo(a)pyrene co-treated with Dextran Sulfate] results in decreased expression of HSPA1B mRNA CTD PMID:26271895 NCBI chr20:4,877,638...4,880,112
Ensembl chr20:2,699,712...2,701,815 		JBrowse link
G Hspg2 heparan sulfate proteoglycan 2 multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HSPG2 mRNA CTD PMID:29950665 NCBI chr 5:155,812,096...155,913,751 JBrowse link
G Htr1b 5-hydroxytryptamine receptor 1B multiple interactions ISO [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of HTR1B mRNA CTD PMID:29950665 NCBI chr 8:89,113,984...89,130,830
Ensembl chr 8:89,129,453...89,130,991 		JBrowse link